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ABSTRACT The basic effector domain of myristoylated alanine-rich C kinase substrate (MARCKS), a major protein kinase C
substrate, binds electrostatically to acidic lipids on the inner leaﬂet of the plasma membrane; interaction with Ca21/calmodulin or
protein kinase C phosphorylation reverses this binding. Our working hypothesis is that the effector domain of MARCKS
reversibly sequesters a signiﬁcant fraction of the L-a-phosphatidyl-D-myo-inositol 4,5-bisphosphate (PIP2) on the plasma
membrane. To test this, we utilize three techniques that measure the ability of a peptide corresponding to its effector domain,
MARCKS(151–175), to sequester PIP2 in model membranes containing physiologically relevant fractions (15–30%) of the
monovalent acidic lipid phosphatidylserine. First, we measure ﬂuorescence resonance energy transfer from Bodipy-TMR-PIP2
to Texas Red MARCKS(151–175) adsorbed to large unilamellar vesicles. Second, we detect quenching of Bodipy-TMR-PIP2 in
large unilamellar vesicles when unlabeled MARCKS(151–175) binds to vesicles. Third, we identify line broadening in the
electron paramagnetic resonance spectra of spin-labeled PIP2 as unlabeled MARCKS(151–175) adsorbs to vesicles.
Theoretical calculations (applying the Poisson-Boltzmann relation to atomic models of the peptide and bilayer) and
experimental results (ﬂuorescence resonance energy transfer and quenching at different salt concentrations) suggest that
nonspeciﬁc electrostatic interactions produce this sequestration. Finally, we show that the PLC-d1-catalyzed hydrolysis of PIP2,
but not binding of its PH domain to PIP2, decreases markedly as MARCKS(151–175) sequesters most of the PIP2.
INTRODUCTION
Although PIP2 comprises only ;1% of the phospholipids in
a plasma membrane from a typical animal cell, it plays a
key role in many cell-signaling pathways. Speciﬁcally, it is
the source of three important second messengers (Berridge
and Irvine, 1984; Payrastre et al., 2001; Cantley 2002;
Vanhaesebroeck et al., 2001) and is involved in membrane
trafﬁcking (Czech, 2003; Cremona and De Camilli, 2001;
Martin, 2001; Osborne et al., 2001; Simonsen et al., 2001); it
also modulates several ion channels (Hilgemann et al., 2001;
Runnels et al., 2002; Prescott and Julius, 2003), mediates
cytoskeleton-membrane interaction (Yin and Janmey, 2003;
Raucher et al., 2000), and regulates the activity of a variety
of molecules (e.g., PLD (Sciorra et al., 2000); N-WASP
(Lim, 2002). How does one lipid play so many different
roles? We and others have hypothesized that proteins bind
a signiﬁcant fraction of the PIP2 in the plasma membrane,
then release it locally in response to speciﬁc signals (Caroni,
2001; McLaughlin et al., 2002). Putative PIP2-sequestering
proteins should satisfy three criteria: they must be present at
concentrations comparable to PIP2, bind PIP2 with high
afﬁnity, and release it locally in response to speciﬁc stimuli
such as an increase in the local calcium ion concentration.
One such candidate is the myristoylated alanine-rich C
kinase substrate (MARCKS) protein (Aderem, 1992; Black-
shear, 1993;McLaughlin and Aderem, 1995; Arbuzova et al.,
1998, 2002). Other viable candidates include GAP43 and
CAP23 in neuronal tissue (Laux et al., 2000). As illustrated
in Fig. 1 A, MARCKS is a natively unfolded protein that
binds to the plasma membrane through hydrophobic in-
sertion of its N-terminal myristate (shown in yellow) and
electrostatic interaction of its basic effector domain with
acidic lipids (shown in the box). The available evidence
suggests that MARCKS may satisfy the three criteria listed
above. First, MARCKS is present at high concentrations
(;10 mM) in neuronal and other tissues (Blackshear, 1993;
Albert et al., 1987); all measurements to date indicate this is
in the same range as the PIP2 concentration. PIP2 comprises
0.3–1.5% of the phospholipid in the plasma membrane of
mammalian erythrocytes (Ferrell and Huestis, 1984; Hagel-
berg and Allan, 1990), lymphocytes (Mitchell et al., 1986),
and hepatocytes (Tran et al., 1993); for a 10-mm cell, this
corresponds to an effective concentration of PIP2 of 5–30
mM. Bunce et al. (1993) determined that the total concen-
tration of PIP2 in human myeloid cells is ;30 mM. Studies
using GFP-PH domain constructs also suggest the effec-
tive concentration of PIP2 in cells is 2\ [PIP2]\ 30 mM,
as discussed elsewhere (McLaughlin et al., 2002). Sec-
ond, a peptide corresponding to the effector domain,
MARCKS(151–175), binds with high afﬁnity to phospho-
lipid vesicles containing a mixture of the zwitterionic lipid
phosphatidylcholine (PC) and PIP2 (Arbuzova et al., 2000b;
Wang et al., 2001, 2002; Rauch et al., 2002). As illustrated in
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Fig. 1 A, the effector domain interacts with approximately
three PIP2 to form an electroneutral complex. This report
provides evidence that MARCKS(151–175) can laterally
sequester PIP2 in the presence of a signiﬁcant excess of
monovalent acidic lipids. Third, the sequestration of PIP2
can be reversed by protein kinase C (PKC) phosphorylation
or by interaction with calcium/calmodulin (Ca21/CaM).
Introduction of three negatively charged phosphates by PKC
or binding of Ca21/CaM causes translocation of both the
MARCKS protein (Kim et al., 1994) and MARCKS(151–
175) (Arbuzova et al., 1998) from the membrane to solution
by diminishing its electrostatic binding to acidic phospholi-
pids. The translocation of the native MARCKS protein from
the plasma membrane due to PKC phosphorylation or Ca21/
CaM binding has been observed in vivo (Swierczynski and
Blackshear, 1995; Ohmori et al., 2000; J. Sable and M. P.
Sheetz, Columbia University, personal communications).
Structural studies have revealed how a peptide corre-
sponding to the MARCKS effector domain interacts with
both Ca21/CaM and membranes. The crystal structure of the
peptide-Ca21/CaM complex reveals the peptide is highly
elongated, with a ‘‘short one-turn helix surrounded by two
loops’’ (Yamauchi et al., 2003). More relevant to the work
reported here, recent structural studies support the molecular
model of MARCKS(151–175) overlaid on a bilayer shown
in Fig. 1 B. Speciﬁcally, electron paramagnetic resonance
(EPR) (Qin and Caﬁso, 1996) and circular dichroism (Wang
et al., 2001) studies indicate the effector domain peptide is
unstructured and elongated, both in solution and when bound
to a membrane. EPR (Qin and Caﬁso, 1996; Victor et al.,
1999) and high resolution NMR experiments in bilayers
(Zhang et al., 2003) and bicelles (Ellena et al., 2003)
demonstrate that the ﬁve phenylalanine residues (shown in
green in Fig. 1 B) penetrate into the acyl chain region of the
bilayer. This penetration must drag the backbone of the
adjacent residues deep into the polar headgroup region; the
charges on these basic residues may ‘‘snorkel’’ up to the
water-polar headgroup interface as illustrated in Fig. 1 B
(Segrest et al., 2002; Strandberg et al., 2002). Available EPR
evidence (Qin and Caﬁso, 1996) suggests that the highly
charged cluster of basic residues at the N-terminus is in the
water phase, as expected from Born energy considerations
and seen experimentally for adsorbed pentalysine peptides
(Roux et al., 1988). The basic cluster at the C-terminus is
also shown in the water phase in Fig. 1 B.
Arbuzova et al. (1998) discuss the evidence that the
MARCKS(151–175) peptide is a good model for studying
the interaction of MARCKS with membranes. For example,
the peptide binds Ca21/CaM with the same high (;4 nM)
afﬁnity as the intact protein and contains the three serine
residues phosphorylated by PKC; either binding of Ca21/
CaM or phosphorylation by PKC produce translocation of
both protein and peptide from membrane to solution. There
is strong evidence that the MARCKS(151–175) peptide
binds with high afﬁnity to PIP2/PC vesicles by electrostat-
ically sequestering approximately three PIP2 (Wang et al.,
2002; Rauch et al., 2002). There is only indirect evidence,
however, that the effector domain can sequester PIP2 when
the membrane contains a physiological mol fraction of
monovalent acidic lipids (i.e., 15–30% phosphatidylserine
(PS) (White, 1973; Yorek, 1993)); speciﬁcally, both
MARCKS and MARCKS(151–175) inhibit the PLC-cata-
lyzed hydrolysis of PIP2 in vesicles or monolayers contain-
ing both PS and PIP2 (Murray et al., 2002; Wang et al.,
2002). We have used three different techniques, ﬂuorescence
resonance energy transfer (FRET), quenching, and EPR, to
obtain more direct evidence that the effector domain of
MARCKS can sequester PIP2 when PS is present.
We ﬁrst measured FRET between labeled
MARCKS(151–175) and PIP2 using PC/PS/PIP2 vesicles
containing 0.1% PIP2 and up to 30% PS. We eliminated the
possibility that sequestration of PIP2 is due to probe-probe
interactions by measuring the effect of unlabeled
MARCKS(151–175) on the quenching of ﬂuorescent PIP2
FIGURE 1 (A) Cartoon of the ‘‘natively unfolded’’ MARCKS protein,
shown as a black line, interacting with the inner leaﬂet of the plasma
membrane. The N-terminal myristate, shown in yellow, inserts hydrophobi-
cally into the bilayer. The MARCKS effector domain (residues 151–175 of
bovine MARCKS, shown in the box) interacts electrostatically with acidic
lipids (3 PIP2 shown in red) through its 13 basic residues (in blue with 1
signs) and hydrophobically through its ﬁve aromatic residues (in green). (B)
Molecular model of a peptide corresponding to the MARCKS effector
domain overlaid on a molecular model of a bilayer membrane. Experimental
evidence (see text) shows that the peptide is located at the polar headgroup
region in an extended conformation; the ﬁve aromatic phenylalanine
residues (colored green) penetrate to the level of the acyl chains, and the
highly charged N-terminal region (basic residues colored blue) is in the
aqueous phase. The lipids are shown in white with the carbonyl oxygen
atoms colored red to illustrate the interface between the headgroup region
and the hydrocarbon interior of the membrane. The extended peptide is ;9
nm in length.
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and on the EPR spectra of spin-labeled PIP2 in these PC/PS/
PIP2 vesicles.
Calculations using atomic-level models of bilayers and
adsorbed basic peptides show that the peptides produce a
local positive electrostatic potential, even when the mem-
brane contains 30% monovalent acidic lipid; this positive
potential should electrostatically sequester the multivalent
acidic lipid, PIP2. To test that the sequestration is due to
electrostatics, we measured the effect of increasing the salt
concentration on lateral sequestration.
Aromatic Phe residues embedded within a basic peptide
drag the adjacent basic residues into the polar headgroup
region (Fig. 1 B). Our electrostatic model predicts that this
should increase the positive potential produced by the
peptide when it adsorbs to the bilayer. Hence, aromatic
residues should enhance PIP2 sequestration. To test this
prediction, we compare the PIP2 sequestration produced by
MARCKS(151–175) versus FA-MARCKS(151–175), a pep-
tide synthesized with alanine residues substituted for
phenylalanine (Table 1).
Finally, we explored the effect of this sequestration on the
activity and membrane binding of phosphoinositide speciﬁc
phospholipase C (PLC). The ﬁve PLC families (Berridge
et al., 2003; Rhee, 2001; Rebecchi and Pentyala, 2000;
Williams and Katan, 1996) catalyze the hydrolysis of PIP2 to
two important second messengers, IP3 and DAG (Berridge
and Irvine, 1984). We ﬁrst tested whether sequestration of
PIP2 by MARCKS(151–175) inhibits PLC-d1 activity, then
examined how sequestration affects the membrane binding
of the PLC-d1 PH domain, which anchors the enzyme to the
plasma membrane by forming a speciﬁc 1:1 complex with
PIP2 (Ferguson et al., 1995; Lemmon, 2003).
MATERIALS AND METHODS
Materials
Fig. 2 shows the structures of the ﬂuorescent and spin-labeled PIP2 lipids
that we used in these studies. Bodipy-TMR-PIP2 (Fig. 2 A) was purchased
from Echelon (Salt Lake City, Utah) as a triethylammonium salt.
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (PC), 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphatidylserine, and the ammonium salt of PIP2
were purchased from Avanti Polar Lipids (Alabaster, AL). Radioactively
labeled [dioleoyl-1-14C]-L-a-dioleoyl-phosphatidylcholine (14C-DOPC) and
[inositol-2-3H(N)]-L-a-phosphatidyl-D-myo-inositol 4,5-bisphosphate (3H-
PIP2) were from Perkin Elmer Life Sciences (Boston, MA). Texas Red C5
bromoacetamide, Bodipy-507 iodoacetamide, Oregon Green 488 malei-
mide, ﬂuorescein-5-iso-thiocyanate (FITC), and N-(6- tetramethylrhodami-
nethiocarbamoyl)-1,2-dihexadecanoyl-sn-glycero-3- phosphoethanolamine
(TRITC-PE) were from Molecular Probes (Eugene, OR). The Molecular
Probes catalog illustrates the structures of these ﬂuorescent probes. FITC-
labeled neomycin (Arbuzova et al., 2000a) was obtained from Glenn
Prestwich (Echelon). Recombinant human PLC-d1 was puriﬁed from
Escherichia coli as described elsewhere (Garcia et al., 1995). The EGFP-
PLC-d1 PH domain construct (EGFP-PH domain) was prepared in E. coli as
described elsewhere (Pentyala at al., 2003; Tall et al., 2000).
Peptides
All peptides, listed in Table I, were obtained from American Peptide
Company (Sunnyvale, CA). The ﬁnal labeled or unlabeled peptides used for
experiments were determined to be[95% pure by HPLC and MALDI-TOF
mass spectroscopy.
Peptide labeling
We used a protocol modiﬁed from ‘‘Conjugation with Thiol-Reactive
Probes’’ (Molecular Probes) to label peptides with the thiol-reactive
ﬂuorescent probes. In brief, we mixed 1 ml of ;1 mM peptide in 10 mM
K2HPO4/KH2PO4, pH 7.0 with the probe dissolved in N,N9-dimethylfor-
mamide (probe-to-peptide molar ratio of ;1:1) for 1 h. We puriﬁed the
labeled peptide using high-performance liquid chromatography and checked
that it has the correct molecular weight using MALDI-TOF mass spectro-
meter (Proteomics Center, SUNY at Stony Brook, Stony Brook, NY).
Vesicle preparations
We used 100-nm diameter large unilamellar vesicles (LUVs) for the FRET,
self-quenching, PLC-d1 hydrolysis, and centrifugation binding experiments,
as described in detail elsewhere (Wang et al., 2002). Brieﬂy, we added
solutions of PIP2 (or Bodipy-TMR-PIP2), PS, and PC in chloroform to a 50-
ml round-bottom ﬂask, which was then well immersed in a 30–358C water
bath and attached to a rotary evaporator. The ﬂask was rotated without
vacuum for ;5 min to warm the ﬂask and solution. We then rapidly
evaporated most of the solvent by applying the maximum vacuum that does
not boil the chloroform. (Rapid evaporation is required to produce a uniform
mixture of PC, PS, and PIP2 because PIP2 is less soluble in chloroform than
either PC or PS.) The ﬂask was kept under full vacuum for $30 min to
remove all traces of chloroform. A solution containing 100 mM KCl, 1 mM
MOPS, pH 7.0 was added for most of our experiments. Subsequently, we
rapidly froze and thawed the multilamellar vesicles ﬁve times. Finally, we
formed LUVs by extrusion of the multilamellar vesicles through 100-nm
diameter polycarbonate ﬁlters. (A solution containing 176 mM sucrose, 1
mM MOPS, pH 7.0 was added to make sucrose-loaded LUVs for
centrifugation binding measurements. The solution bathing the LUVs was
then exchanged for 100 mM KCl, 1 mM MOPS, pH 7.)
Preparation of lipid vesicles for EPR spectroscopy
LUVs (100 nm) were prepared as described previously by mixing
appropriate volumes of stock solutions of POPC and POPS in chloroform,
drying the lipid mixtures under vacuum, hydration of the lipid in 100 mM
TABLE 1 Sequences of peptide
Peptide Sequence
MARCKS(151–175) Ac-KKKKKRFSFKKSFKLSGFSFKKNKK-
NH2
FA-MARCKS(151–175) Ac-KKKKKRASAKKSAKLSGASAKKN-
KK-NH2
Lys-13 Ac-KKKKKKKKKKKKK-NH2
Lys-7 Ac-KKKKKKK-NH2
Basic (lysine or arginine) residues are in bold. Aromatic (phenylalanine)
residues are underlined. The N-terminus of each peptide is blocked with an
acetyl group (Ac-) and the C-terminus is blocked with an amide group
(-NH2). For ﬂuorescent probe labeling, peptides were synthesized with
a cysteine residue at the N-terminus. The sequence for MARCKS(151–175)
shown here is identical for bovine (151–175) and murine (145–169)
MARCKS effector domains.
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KCl, 10 mMMOPS, pH 7.0 followed by extrusion through 100-nm pore size
polycarbonate ﬁlters (Rauch et al., 2002). The spin-labeled proxyl-PIP2
(shown in Fig. 2 B; provided by G. Prestwich and C. Ferguson, Echelon, Salt
Lake City, UT) was incorporated into the outer leaﬂet of the vesicles by
adding the lipid vesicle suspension to a dried ﬁlm of labeled lipid. As
discussed previously, this procedure resulted in incorporation of the proxyl-
PIP2 into the outer leaﬂet of the vesicle bilayer (Rauch et al., 2002).
FRET experiments
FRET and other ﬂuorescence experiments were performed on an SML-
AMINCO spectroﬂuorometer. FRET experiments used LUVs prepared with
0.1% Bodipy-TMR-PIP2 (shown in Fig. 2 A) incorporating varying mol
fractions of POPS and POPC. We excited the donor ﬂuorophore and
collected the complete emission spectra. When Bodipy-TMR-PIP2 was the
donor and Texas Red MARCKS(151–175) the acceptor, we excited at 547
nm and collected emission spectra from 560 to 660 nm. Direct binding
measurements using the centrifugation technique (not shown) allowed us to
choose a sufﬁciently high lipid concentration so that essentially all the
peptide we added was bound to the LUVs; we monitored FRET as peptide
was added to the solution containing the LUVs. We deconvoluted the data
by performing a four-parameter two-peak Lorentzian ﬁt keeping the peak
wavelengths ﬁxed at 571 nm for the Bodipy-TMR-PIP2 and at 607 nm for
Texas Red MARCKS(151–175). After checking the quality of ﬁt, we used
the peak amplitudes and full width at half-maximum amplitude for each peak
to calculate the ﬂuorescence intensity. The energy transfer efﬁciency, %
transfer, was analyzed by calculating the quenching of the ﬂuorescence
intensity of the donor,
% transfer ¼ 1 IdaðlÞ
IdðlÞ ; (1)
where Ida is the donor ﬂuorescence intensity determined at the given
excitation wavelength, l, in the presence of the acceptor, and Id is the
corresponding intensity in the absence of the acceptor. The % transfer was
also determined by calculating the ﬂuorescence intensity of the acceptor,
% transfer ¼ eadðl1Þ
edaðl1Þ
Iadðl2Þ
Iaðl2Þ  1
 
; (2)
where ead is the absorbance of the acceptor when donor is present; eda is the
absorbance of the donor when acceptor is present; l1 is the peak absorbance
wavelength of the donor; Iad is the intensity determined at the acceptor
wavelength, l2, in the presence of the donor; and Ia is the corresponding
intensity in the absence of the donor (Berney and Danuser, 2003; Lakowicz
1999; Van Der Meer et al., 1994).
We performed two control measurements to estimate effects due to
probe-probe interactions and other artifacts. First, we replaced ﬂuorescent
PIP2 with TRITC-PE, a zwitterionic lipid that should not be sequestered by
ﬂuorescent MARCKS(151–175) and should not exhibit FRET. TRITC is
a rhodamine analog that has excitation and emission spectra comparable to
the Bodipy-TMR. Second, we added 1–5 nM of PLC-d1 to hydrolyze the
Bodipy-TMR-PIP2 on the same vesicles used to perform FRET experiments.
The amount of FRET was remeasured on these hydrolyzed vesicles.
We performed FRET experiments with vesicles containing 0.1% or 1%
ﬂuorescent PIP2. We note, however, that random interactions produced
signiﬁcant energy transfer when Texas-Red-labeled peptide bound to
vesicles containing 1% ﬂuorescent PE (an electrostatically neutral lipid that
should not bind to the basic peptides) instead of ﬂuorescent PIP2. This is
expected because, for a vesicle containing 1% ﬂuorescent lipid, the average
distance between a ﬂuorophore on the lipid and a ﬂuorophore on the peptide
is;50 A˚, which is approximately the Ro value for the ﬂuorophores we used
(Fluorescence Resonance Energy Transfer in Molecular Probes Handbook).
For a vesicle containing 0.1% ﬂuorescent lipid, the average distance between
the ﬂuorophores on the peptide and lipid is ;160 A˚; thus, FRET
measurements of lateral interaction are more informative at the lower PIP2
concentration. Moreover, measurements using 0.1% PIP2 are a more
stringent test of our hypothesis that much of the PIP2 is sequestered under
physiological conditions.
Quenching experiments
Bodipy-TMR-PIP2 was excited at 547 nm and emission spectra were
recorded from 560 to 660 nm in the presence of different concentrations of
unlabeled peptide. We calculated the % quenching as described above using
FIGURE 2 Molecular structures of
(A) Bodipy-TMR-PIP2 and (B) proxyl-
PIP2 .
Electrostatic Sequestration of PIP2 2191
Biophysical Journal 86(4) 2188–2207
Eq. 1 (Berney and Danuser, 2003; Lakowicz 1999; Van Der Meer et al.,
1994). The vesicle concentration was sufﬁciently high that essentially all the
peptide added to the solution bound to the membrane. We excluded
quenching artifacts by performing control experiments on vesicles in which
the negatively charged Bodipy-TMR-PIP2 was replaced with zwitterionic or
neutral ﬂuorescent lipids (TRITC-PE or Bodipy-TMR-DAG), as discussed
in the FRET section above.
The average distance between PIP2 molecules is;100 A˚ and;300 A˚ in
vesicles containing 1% and 0.1% PIP2, respectively; the Ro value of the
Bodipy-TMR probe is;50 A˚, so self-quenching should be negligible in the
absence of peptide. Indeed, for #1% Bodipy-TMR-PIP2, ﬂuorescence
increases linearly with the % labeled PIP2 in the vesicles. We observed
qualitatively similar results in experiments performed with vesicles contain-
ing either 1% or 0.1% Bodipy-TMR-PIP2, but present data only for the
vesicles with 1%Bodipy-TMR-PIP2, where the effect was more pronounced.
EPR spectroscopy
EPR spectra were recorded at X-band from;5 mL of sample using a Varian
E-line Century series spectrometer ﬁtted with a MITEQmicrowave ampliﬁer
(Hauppauge, NY) and a two-loop one-gap resonator (Medical Advances,
Milwaukee, WI). Spectra were recorded using a modulation of 1 Gauss
peak-to-peak and microwave power of #2 mW.
EPR spectra with titration of MARCKS(151–175) were performed by
adding concentrated solutions of the peptide to;100 mL of a 7–20 mM lipid
vesicle suspension with 0.25–0.85 mol% proxyl-PIP2 incorporated into the
outer leaﬂet. Spectra were recorded by withdrawing a small sample of the
vesicle suspension into the loop-gap resonator as described previously
(Rauch et al., 2002). The binding of MARCKS(151–175) to proxyl-PIP2
was analyzed by recording the amplitude of the ﬁrst derivative peak-to-peak
EPR spectrum.
Measurement of PIP2 Hydrolysis
We previously reported that MARCKS and a peptide corresponding to its
effector domain inhibit PLC-catalyzed PIP2 hydrolysis (Wang et al., 2001,
2002; Murray et al., 2002). In those experiments, however, the vesicles or
monolayers contained 1% PIP2 and a high concentration of protein or
peptide was needed to inhibit the hydrolysis. The experiments reported here
used vesicles containing only 0.1% PIP2, allowing us to use lower con-
centrations of peptide and minimize effects other than PIP2 sequestration
(for example, effects due to the insertion of Phe residues into the acyl chain
region of the bilayer or to the charges on the peptide decreasing the net
negative charge of the PC/PS/PIP2 bilayer).
We added PLC-d1 to vesicles containing
3H-PIP2 and terminated
hydrolysis at different times by adding 375 ml ice-cold 10% trichloroacetic
acid and 50 ml 10% Triton X-100 to 75 ml of the reaction mixture, then
incubating the samples on ice until a white precipitate formed. The samples
were then centrifuged at 14,000 3 g for 5 min and the supernatant was
mixed with 1 ml of chloroform/methanol (2:1 volume ratio); subsequently,
the upper phase containing the 3H-IP3 products was transferred to
a scintillation vial for counting.
Data were analyzed by ﬁrst plotting the % PIP2 hydrolyzed versus time
(Fig. 13 A). We obtained the rate of hydrolysis or PLC-d1 activity by
calculating the initial (ﬁrst 2–3min) slopes from the time curves of individual
experiments. Because PLC-d1 activity varies from one day to the next, we
normalized the activity to controls where no peptide was present; the data in
Fig. 13 B are averages of normalized activity from individual experiments.
Binding experiments with EGFP-PH domain
and FITC-neomycin
We measured the binding of EGFP-PH domain or FITC-neomycin to
sucrose-loaded PC/PIP2 LUVs using the centrifugation technique described
previously (Buser and McLaughlin, 1998). The technique gives results
similar to other techniques used to study binding of peptide to membrane
(Simon and McIntosh, 2002). Brieﬂy, sucrose-loaded PC/PIP2 LUVs were
mixed with trace concentrations of labeled peptide or protein (typically 5–20
nM), and the mixture was centrifuged at 100,0003 g for 1 h. We calculated
the percentage of peptide or protein bound by comparing ﬂuorescence in the
supernatant and the pellet. Measurements of the binding to PC vesicles
containing 1%, 0.1%, or 0.03% PIP2 are consistent with the formation of
a 1:1 complex (Ferguson et al., 1995) and show that the EGFP-PH domain
binds to PIP2 with a Kd of 1.6 6 0.4 mM (data not shown). We measured
a similar value for the Kd when we used 5:1 PC:PS vesicles with 1% PIP2.
This Kd value is consistent with the value in literature for the PH domain of
PLC-d1 (Harlan et al., 1994; Lemmon et al., 1995; Garcia et al., 1995). A
minor problem with our EGFP-PH domain construct is that it aggregates,
and some resulting multimers are in the pellet. We attempted to diminish
these problems by precentrifuging the EGFP-PH domain and using the
primarily monomeric EGFP-PH domain from the supernatant; we also used
a low concentration of detergent 0.0065% Triton X-100, which does not
destroy the vesicles (Buser et al., 1994), to solubilize the EGFP-PH in our
experiments.
Electrostatic calculations
Electrostatic potentials and free energies are obtained from a modiﬁed
version of the DelPhi program (Gallagher and Sharp, 1998) that solves the
nonlinear Poisson Boltzmann (PB) equation for protein/membrane systems
(Ben-Tal et al., 1996). DelPhi produces ﬁnite difference solutions to the PB
equation (the FDPB method) for a system where the solvent is described in
terms of a bulk dielectric constant and concentrations of mobile ions,
whereas solutes (here, basic peptides, the PLC-d1 PH domain, PIP2, and
phospholipid membranes) are described in terms of the coordinates of the
individual atoms as well as their atomic radii and partial charges (Brooks
et al., 1983; Peitzsch et al., 1995).
The application to the PIP2/peptide/membrane systems considered here is
described in more detail in our companion computational paper (Wang et al.,
2003). PIP2 is assumed to have a valence of 4 and the basic peptides are
assumed to be in their minimum free-energy orientations as determined for
the interaction with PC/PS bilayers in 0.1 M KCl in the absence of PIP2; i.e.,
it is assumed that the interaction with PIP2 does not affect the orientation of
the basic peptides at the membrane surface. The structure of the PH domain
from PLC-d1 (Ferguson et al., 1995) was used in the calculation of the
electrostatic potentials illustrated in Fig. 15. The electrostatic potentials
depicted in Figs. 12 and 15 were calculated by solving the nonlinear PB
equation (Gallagher and Sharp, 1998) and visualized in GRASP (Nicholls
et al., 1991).
Preparation of giant vesicles for microscopy
Giant unilamellar vesicles for microscopy studies were prepared using
a gentle hydration method (Akashi et al., 1996). An appropriate lipid
mixture in chloroform was dried in a ﬂask on a rotary evaporator under
vacuum for 30 min to form a thin ﬁlm. The dried ﬁlm was prehydrated for
20 min with water-saturated argon at 408C, and 1–4 ml of buffer solution
was gently added to the ﬂask. The sealed ﬂask was incubated at room
temperature for 12 h, and 100–200 ml of the upper part of the solution was
harvested and used for microscopy studies. Images were obtained using
a ﬁxed stage microscope (Axioskop, Carl Zeiss, Go¨ttingen, Germany), Plan-
NEOFLUOR 633-oil objective (Carl Zeiss), and Micro-Max Princeton
CCD camera (Princeton Instruments, Trenton, NJ). The Texas Red
ﬂuorescence was measured using a short band-pass ﬁlter set XF43 from
Omega Optical (Brattleboro, VT): exciter 580DF27 nm, beam splitter 600
nm, and emitter 630DF30 nm.
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RESULTS
FRET shows membrane-bound MARCKS(151–175) se-
questers PIP2, even when the vesicles contain a 300-fold
excess of PS. Fig. 3 A shows energy transfer from Bodipy-
TMR-PIP2 to membrane-bound Texas Red MARCKS(151–
175) as the peptide concentration increases from 0 to 200 nM.
Fig. 3, B and C, show the deconvoluted, emission spectra of
the two ﬂuorophores. As the peptide concentration increases,
the donor (Bodipy-TMR-PIP2) ﬂuorescence decreases (Fig.
3 B) and the acceptor ﬂuorescence increases (Fig. 3 C). Fig. 4
shows the % energy transfer calculated using both the
quenched Bodipy-TMR ﬂuorescence (d) and the energy
transferred Texas Red ﬂuorescence () data. The two calcu-
lations agree, as they should. These experiments illustrate
that the Bodipy-TMR-PIP2 transfers energy effectively to
membrane-bound Texas Red MARCKS(151–175) on LUVs
containing 30% monovalent acidic lipids, suggesting that the
basic peptide sequesters the multivalent acidic lipid PIP2
under physiological conditions (i.e., 300-fold excess PS).
We performed FRET experiments similar to those shown
in Figs. 3 and 4 (0.75 mM lipid concentration) at two
additional lipid concentrations: 0.1 mM and 0.5 mM. Fig. 5
compares the results obtained at the different lipid concen-
trations, plotting the % energy transfer against the ratio of the
peptide concentration to the total PIP2 concentration in the
solution. Because the sequestration represents a lateral
interaction between the membrane-bound peptide and PIP2,
we expect the % energy transfer to be independent of the
lipid concentration and to depend only on the peptide:PIP2
molar ratio. The results shown in Fig. 5 agree qualitatively
with this expectation. Note that the % transfer approaches
100% as the peptide concentration (i.e., peptide:PIP2 ratio)
increases. This is surprising: we expected that the polyvalent
peptide would undergo FRET with only the PIP2 on the outer
leaﬂet because it would not permeate the LUVs. The simplest
interpretation is that the Texas Red MARCKS(151–175)
permeates the bilayer and binds to PIP2 on both the inner and
outer leaﬂets of the vesicles. Appendix 1 presents direct
experimental support for this interpretation.
We used the data in Fig. 5 to estimate the apparent Kd for
the lateral binding of PIP2 to MARCKS(151–175) by making
three key assumptions: i), the surface phase containing both
the PIP2 and the membrane-bound MARCKS(151–175) may
be considered to be a three-dimensional phase of molecular
(1 nm) thickness (Guggenheim approximation; Aveyard and
Haydon, 1973); ii), the area occupied by the lipids is 0.7
nm2; and iii), 50% of the PIP2 is bound when the % transfer
is 50%. With these and other assumptions, we deduce that
the apparent Kd; 1 mM (or stronger) and that the magnitude
FIGURE 3 FRET from Bodipy-TMR-PIP2 to membrane-bound Texas
Red MARCKS(151–175). The LUVs are formed from PC/PS/Bodipy-
TMR-PIP2 (70:30:0.1). The total lipid concentration is 0.75 mM;
approximately all the peptide is bound to the LUVs. Bodipy-TMR-PIP2 is
excited at 547 nm. (A) Representative corrected emission spectra for the
peptide concentrations indicated. Spectra are deconvoluted to two peaks: (B)
the quenching of Bodipy-TMR-PIP2, centered at 571 nm, and (C) the energy
transfer to Texas Red MARCKS(151–175), centered at 607 nm. The
solutions in these experiments, and in those shown in the following ﬁgures
(except Figs. 9 and 13), contain 100 mM KCl, 1 mM MOPS, pH 7.0.
FIGURE 4 The % energy transfer versus concentration of Texas Red
MARCKS(151–175). We calculate the % energy transfer from the
quenching data (d) in Fig. 3 B and similar experiments, or from the energy
transferred data () in Fig. 3 C and similar experiments. All subsequent
energy transfer results are calculated using the quenching spectra. Each point
shown in the graph is an average of $7 separate experiments (6SD).
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of the binding energy (DG9¼ RT ln Kd) is$4 kcal/mol for
this lateral interaction.
We also studied FRET to Bodipy-TMR-PIP2 using
peptides labeled with donor ﬂuorophores (Bodipy-507 or
Oregon Green) and obtained results similar to those shown
for Texas Red MARCKS(151–175) (data not shown).
Speciﬁcally, 200–300 nM of either Bodipy-507-
MARCKS(151–175) or Oregon Green MARCKS(151–
175) energy transferred ;50% to Bodipy-TMR-PIP2 on
PC/PS/Bodipy-TMR-PIP2 (70:30:0.1) LUVs, as observed in
Fig. 4 with the Texas Red label. The energy transfer with
these probes also approached 100% quenching for high ([5)
peptide:PIP2 ratios. MARCKS(151–175) labeled with these
hydrophobic probes also rapidly permeates vesicles (see
Appendix 1).
The data shown in Figs. 3, 4, and 5 were obtained with
vesicles containing 30% PS. We also performed experiments
with vesicles containing 0%, 10%, and 17% PS (data not
shown). The 0% PS data are consistent with spin label
(Rauch et al., 2002), kinetic (Wang et al., 2002), competi-
tion, and z-potential (Wang et al., 2001) measurements that
show each membrane-bound MARCKS(151–175) seques-
ters approximately three PIP2 on a PC/PIP2 membrane. As
expected, the vesicles with 10% and 17% PS show stronger
energy transfer than those with 30% PS. Because biological
membranes contain PE and cholesterol as well as PC, PS,
and PIP2 (White, 1973; Yorek, 1993), we measured FRET
with 1:1:1:1 POPC:POPS:POPE:cholesterol 1 0.1% Bodi-
py-TMR-PIP2 LUVs; the energy transfer was comparable to
that illustrated in Fig. 4 (data not shown). Appendix 2
considers in more detail the role of cholesterol in the binding
of MARCKS effector domain to membranes.
Effect of aromatics
Fig. 6 shows the effect of replacing the ﬁve aromatic (Phe)
residues in Texas Red MARCKS(151–175) with Ala: Texas
Red FA-MARCKS(151–175) showed approximately two-
fold weaker energy transfer than Texas Red MARCKS(151–
175), indicating that the aromatics increase the sequestration
of PIP2. The lipid concentration was 0.75 mM, sufﬁcient to
bind essentially all of the peptide.
Effect of linear density of basic residues
Texas-Red-labeled Lys-7 and Lys-13 showed a concentra-
tion-dependent energy transfer similar to that observed with
Texas Red MARCKS(151–175); Fig. 6 shows only the data
obtained at 200-nM peptide concentration. Labeled Lys-13
(.) produces greater quenching than labeled FA-
MARCKS(151–175) (), consistent with our prediction that
increasing the linear charge density should increase the
electrostatic sequestration. Note that the labeled Lys-7 and
Lys-13 peptides both produce strong sequestration. In
summary, FRET experiments illustrate that MARCKS(151–
175) can sequester PIP2 on LUVs containing a physiological
mol fraction of monovalent acidic lipid (15–30%).
One potential complication with these experiments is that
direct interactions may occur between the ﬂuorophores on
the peptide and on PIP2. We performed control FRET
FIGURE 5 The % energy transfer for PC/PS/Bodipy-TMR-PIP2
(70:30:0.1) LUVs plotted against the molar ratio of Texas Red
MARCKS(151–175) to Bodipy-TMR-PIP2. The total lipid concentrations
are 0.75 mM (.), 0.5 mM (), and 0.1 mM (d).
FIGURE 6 The % energy transfer from Bodipy-TMR-PIP2 to Texas-Red-
labeled peptides: Texas Red MARCKS(151–175) (d),Texas Red FA-
MARCKS(151–175) (), Texas Red Lys-13(.), and Texas Red Lys-7(,).
The total lipid concentration is 0.75 mM in PC/PS/Bodipy-TMR-PIP2
(70:30:0.1) LUVs.
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experiments using Bodipy-TMR-DAG, which is produced
by hydrolyzing Bodipy-TMR-PIP2 with PLC-d1; the same
vesicles used in the original FRET measurements were
hydrolyzed. Because Bodipy-TMR-DAG is electrically
neutral, we expect no electrostatic sequestration and no
energy transfer between Bodipy-TMR-DAG and Texas Red
MARCKS(151–175). The energy transfer (not shown) is
signiﬁcantly less than illustrated in Fig. 4 (maximum ;10%
transfer rather than;50%), and similar results were obtained
using TRITC-PE instead of Bodipy-TMR-PIP2. Thus, most
of the FRET seen in Figs. 4–6 is due not to probe-probe
interaction but to lateral interaction of MARCKS(151–175)
with PIP2. We used two techniques, quenching and EPR, to
perform experiments with unlabeled peptide, which allowed
us to eliminate any probe-probe interactions and to test the
possibility that the probe on the peptide is enhancing the
lateral sequestration of PIP2 by some other mechanism (e.g.,
enhanced image charge effect).
MARCKS(151–175) produces self-quenching of
ﬂuorescent PIP2
Because one MARCKS(151–175) peptide can bind approx-
imately three PIP2 on a PIP2/PC membrane (Rauch et al.,
2002; Wang et al., 2002), we postulated that the peptide
should induce local clustering, and thus self-quenching of
ﬂuorescent PIP2. Fig. 7 A illustrates that unlabeled
MARCKS(151–175) decreases the ﬂuorescence of Bodipy-
TMR-PIP2 in PC/Bodipy-TMR-PIP2 (99:1) vesicles. Fig. 7 B
plots the % quenching of Bodipy-TMR-PIP2 as a function of
MARCKS(151–175) concentration (d); data were from Fig.
7 A and similar experiments. These results are consistent
with previous experiments (spin-label, kinetic measure-
ments, etc.) showing that MARCKS(151–175) can sequester
approximately three PIP2 lipids on a PC/PIP2 membrane.
Our control experiments examined the ability of
MARCKS(151–175) to quench electrostatically neutral
TRITC-PE or Bodipy-TMR-DAG: as expected, no signiﬁ-
cant quenching was observed (data not shown).
Fig. 7 B also shows quenching results obtained with PC/
PS/Bodipy-TMR-PIP2 vesicles containing 17% () and 30%
(.) PS; note that we observed signiﬁcant quenching even in
the presence of 30% PS. Control experiments (not shown)
indicate that the peptide produces a larger self-quenching
effect on the vesicles containing ﬂuorescent PIP2 than ﬂuo-
rescent diacylglycerol (DAG).
Fig. 8 shows similar quenching measurements using either
unlabeled FA-MARCKS(151–175) or Lys-13; in contrast to
MARCKS(151–175), these peptides bind outside the
envelope of the polar headgroup region. These measure-
ments allow us to investigate how aromatics and the linear
charge density affect the electrostatic sequestration of PIP2.
MARCKS(151–175) (d) produces stronger quenching of
Bodipy-TMR-PIP2 than FA-MARCKS(151–175) (.); thus,
aromatics enhance the electrostatic sequestration of PIP2.
Lys-13 () produces stronger quenching than FA-
MARCKS(151–175) (.), even though both peptides contain
13 basic residues and no aromatics; the simplest, but not the
only, explanation is that a higher linear density of basic
residues also increases the sequestration. (We note in passing
that if the quenching shown in Figs. 7 B and 8 were due only
to the proximity of the PIP2 bound to the peptide, it would
have exhibited a maximum for 100\ [peptide]\1000 nM,
where the molar ratio of bound peptide to PIP2 decreases to
a value\1. No maxima are observed, which indicates that
other factors contribute to the quenching produced by the
peptide-lipid interaction.)
These quenching results agree qualitatively with the FRET
results: both techniques show that MARCKS(151–175) can
FIGURE 7 Quenching of Bodipy-TMR-PIP2 due to membrane-bound
unlabeled MARCKS(151–175). Total lipid concentration is 0.1 mM.
Bodipy-TMR-PIP2 is excited at 547 nm. (A) Representative experiments
showing the raw emission spectra for Bodipy-TMR-PIP2 at different
concentrations of MARCKS(151–175); vesicles are PC/Bodipy-TMR-PIP2
(99:1) LUVs. (B) The % quenching of Bodipy-TMR-PIP2 as a function of
MARCKS(151–175) concentration on vesicles comprised of PC, 1%
Bodipy-TMR-PIP2, and either 0 (d), 17% (), or 30% (.) PS. Each point
on the plot is an average of $7 independent experiments.
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laterally sequester PIP2, even when the vesicles contain 30%
PS; aromatics increase the sequestration, as predicted by
electrostatic theory (see below).
Increasing the salt concentration decreases the
lateral sequestration of PIP2
If the sequestration of PIP2 by a membrane-bound peptide is
due mainly to electrostatics, theory predicts that sequestra-
tion should decrease as the salt concentration is increased.
FRET measurements with labeled peptides (Fig. 9 A) and
quenching measurements with unlabeled peptides (Fig. 9 B)
show the lateral sequestration of PIP2 indeed decreases as the
salt concentration increases.
EPR experiments show MARCKS(151–175) can
sequester proxyl-PIP2 in the presence of
monovalent acidic lipids
Fig. 10 shows EPR spectra of the proxyl-PIP2 spin label
incorporated into LUVs formed from PC or mixtures of PC
and PS in the absence and presence of MARCKS(151–175).
In each lipid mixture, addition of MARCKS(151–175)
produced a substantial reduction in the EPR resonance
amplitude, reﬂecting a broadening of the normalized EPR
spectrum. Previous studies showed addition of molecules
known to interact with PIP2, such as neomycin and the PH
domain of PLC-d1, decrease the amplitude of the EPR
spectra (Rauch et al., 2002). For MARCKS(151–175), the
decrease in spectral amplitude of proxyl-PIP2 reﬂects an
;30% reduction in the rotational correlation time. Under
certain conditions (for example the PC sample in Fig. 10 A),
dipolar interactions may produce additional broadening
when more than one proxyl-PIP2 lipid is bound to
MARCKS(151–175) (Rauch et al., 2002). The changes seen
upon MARCKS(151–175) addition are reversed when the
peptide is removed from the membrane interface, e.g., by the
addition of Ca21/calmodulin (data not shown).
Fig. 11 shows titrations of the normalized proxyl-PIP2
resonance amplitude upon addition of the MARCKS(151–
175). For proxyl-PIP2 in PC and PC:PS (9:1) LUVs, we
observed similar changes in amplitude, suggesting a similar
afﬁnity between proxyl-PIP2 and MARCKS(151–175) in the
presence or absence of PS. These data could not be ﬁt to
a simple 1:1 binding model, consistent with the idea that
multiple PIP2 are sequestered by the peptide (Wang et al.,
2001; Rauch et al., 2002). When experiments were
performed with 7:3 PC/PS LUVs, the EPR amplitude
approached a similar endpoint, but the apparent afﬁnity of
proxyl-PIP2 for MARCKS(151–175) was lower, in agree-
ment with the ﬂuorescence results shown in Fig. 7.
SUMMARY
FRET, quenching, and EPR experiments all show that the
MARCKS effector domain can laterally sequester PIP2 on
FIGURE 8 Quenching of Bodipy-TMR-PIP2 due to MARCKS(151–175)
(d), Lys-13 (), and FA-MARCKS(151–175) (.). PC/PS/Bodipy-TMR-
PIP2 (69:30:1) LUVs at a lipid concentration of 0.5 mM are sufﬁcient to bind
essentially all of the peptide. FIGURE 9 Increasing the salt concentration decreases both energy
transfer and quenching. (A) Energy transfer between Bodipy-TMR-PIP2
and Texas Red MARCKS(151–175) (d) or Texas Red FA-MARCKS(151–
175) () in solutions containing 100 mM, 200 mM, or 300 mM KCl. Lipid
composition of LUVs is PC/PS/Bodipy-TMR-PIP2 (70:30:0.1). (B)
Quenching of Bodipy-TMR-PIP2 due to MARCKS(151–175) (d), FA-
MARCKS(151–175) (), or Lys-13 (.) in solutions containing 100 mM,
200 mM, or 300 mM KCl. Lipid composition of LUVs is PC/PS/Bodipy-
TMR-PIP2 (69:30:1).
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LUVs with lipid composition comparable to the inner leaﬂet
of the plasma membrane (i.e., 15–30% PS). The next section
shows that electrostatic theory predicts this lateral seques-
tration of a polyvalent lipid.
Calculations of the sequestration of PIP2 by
FA-MARCKS(151–175) provide support for
a nonspeciﬁc electrostatic mechanism
We used the Finite Difference Poisson-Boltzmann (FDPB)
method to examine two hypotheses: i), lateral sequestration
of PIP2 by membrane-adsorbed basic peptides is due to
nonspeciﬁc electrostatic interactions, and ii), electrostatic
sequestration is signiﬁcant, even when the membrane
contains an appreciable mol fraction of PS. The calculations
incorporate molecular models of PIP2, the peptide, and the
PC/PS membrane. Fig. 12 A illustrates the predicted electro-
static properties of a 5:1 PC/PS membrane under a variety of
conditions. The front portion of the ﬁgure represents the
membrane far from either peptide or PIP2: the 25 mV
equipotential proﬁle above this region of ‘‘bulk’’ membrane
undulates gently, with hills corresponding to the location of
the charged PS lipids. The middle portion of Fig. 12 A
illustrates how the adsorption of the basic peptide FA-
MARCKS(151–175) to the membrane surface produces
a highly localized region of positive potential in its vicinity.
The multivalent anionic PIP2 (shown in yellow and visible in
the upper right portion of Fig. 12 A) produces a localized
enhancement of the negative potential of the 5:1 PC/PS
membrane. The membrane-adsorbed FA-MARCKS(151–
175) electrostatically attracts the highly charged PIP2; as
discussed in Wang et al. (2003), the calculated change in
electrostatic free energy when PIP2 partitions from bulk
membrane to a position adjacent to the peptide is 2.2 kcal/
mol (Fig. 12 B). Therefore, FA-MARCKS(151–175)
adsorbed to the surface of a membrane containing 17 mol %
PS provides a strong basin of attraction for the electrostatic
sequestration of PIP2. Additional quantitative results, as well
as the calculated dependence of PIP2 partitioning on the ionic
strength of the solution, the mol percent acidic lipid in the
membrane, and the residue composition of the peptide, are
provided in our companion computational paper (Wang et al.,
2003).
Fig. 12, C–E, provide an alternative representation of
the electrostatic interactions that occur ﬁrst between FA-
MARCKS(151–175) and bulk membrane, then between the
membrane-adsorbed peptide and PIP2. As depicted in Fig. 12
C, FA-MARCKS(151–175) in solution ([KCl] ¼ 0.1 M) has
a strong positive electrostatic proﬁle. Fig. 12 D shows the
decrease in this positive contour when the peptide binds to
the surface of a 5:1 PC/PS membrane (the view is from
above, looking down on the membrane surface). FDPB
calculations indicate this decrease is due to the favorable
electrostatic interaction between the basic peptide and acidic
lipids in the membrane; details of the membrane and its
electrostatic potential have been removed for clarity. Fig. 12
E illustrates how interaction with PIP2 further decreases the
positive contour of the N-terminal portion of the membrane-
adsorbed peptide; this is the same interaction depicted in Fig.
12 B.
Fig. 12, D and F, contrast the positive potential contours
surrounding FA-MARCKS(151–175) and Lys-13, respec-
tively, adsorbed to the surface of a 5:1 PC:PS membrane.
Although both peptides have a net charge of 113, Lys-13
has a signiﬁcantly higher linear charge density. Conse-
quently, FDPB calculations predict that the positive
FIGURE 10 EPR spectra of proxyl-PIP2 in bilayers composed of (A) PC,
(B) PC/PS (9:1), and (C) PC/PS (7:3) in the absence (black line) and
presence (gray line) of MARCKS(151–175). The peptide was added to
concentrations of ;50, 80, and 120 mM in A, B, and C, respectively. The
spin label was present at ;0.5 mol%; total lipid concentration is 20 mM;
solution contains 100 mM KCl, 10 mM MOPS, pH 7.0. The amplitudes of
the EPR spectra have been normalized against the total spin concentration.
FIGURE 11 Titration of the central (mI ¼ 0) nitroxide EPR resonance,
A(0), as a function of the concentration of added MARCKS(151–175). The
titration is shown in vesicle suspensions of PC (), PC/PS (9:1, m), PC/PS
(7:3, d) at a total lipid concentration of ;7 mM; proxyl-PIP2 is present at
0.85 mol%.
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equipotential contour of membrane-adsorbed Lys-13 is
signiﬁcantly larger than that of membrane-adsorbed FA-
MARCKS(151–175), which consists of 25 amino acid
residues. This suggests that Lys-13 interacts with PIP2 more
strongly than FA-MARCKS(151–175) because of its higher
linear charge density.
One limitation of our atomic model is obvious: PS is not at
electrochemical equilibrium, but is assumed to be spatially
ﬁxed. Only PIP2 redistributes (is laterally sequestered) when
the peptide binds to the membrane. Experiments are in
progress to address the possibility that PS is also sequestered
by basic peptides (May et al., 2000) and that when PIP2 is
sequestered from a membrane containing both PS and PIP2,
there is an exchange of several sequestered PS for PIP2.
Simpliﬁed models of peptides and membranes allow one to
take into account the electrochemical equilibrium of both PS
(May et al., 2000; Groves et al., 2000) and PIP2 (Haleva et al.,
2003) as the peptide adsorbs. If the peptide is assumed to be
a disk larger than the Debye length, the charge density on the
membrane beneath the adsorbed disk is approximately
‘‘matched’’ to the charge density on the disk (Haleva et al.,
2003). In this case there is a release of approximately three
PS as one PIP2 is sequestered. The major conclusion of this
disk model agrees with our atomic model calculations: basic
peptides can laterally sequester multivalent anionic lipids
such as PIP2 by an electrostatic mechanism.
Simple electrostatics predicts increased
sequestration due to aromatics
Figs. 6, 8, and 13 B show that aromatic residues embedded in
a cluster of basic residues enhance the lateral sequestration of
PIP2, but how do aromatic residues exert this effect? Fig. 1 B
depicts a model based on the results of several different
experiments showing that the aromatics insert into the acyl
chain region and consequently pull the adjacent basic
residues into the polar headgroup region. Moving a charge
close to or within the polar headgroup region increases the
electrostatic potential it produces—and thus the sequestra-
tion of PIP2—for two reasons. First, when a charge moves
close to a region of low dielectric constant, the ‘‘image
charge’’ effect enhances the potential, as discussed in
standard texts (Dill and Bromberg, 2003; see Chapter 21)
and reviews (McLaughlin, 1989; see Fig. 1). In the simplest
case (no salt in aqueous, a, or membrane, m, phases) moving
a single point charge from a medium of dielectric 80 to the
interface with a homogeneous phase of dielectric 2 increases
the potential by a factor 2ea/(em 1 ea)  2 at any distance
from the charge (see Fig. 4.4 in Jackson, 1975). Second, if
the aqueous phase contains salt, and the membrane phase
does not, moving a point charge q to the interface perturbs
the ion atmosphere around the charge. Even if image charge
effects are absent (e.g., dielectric constant of the membrane
phase is identical to that of the aqueous phase), the potential
increases at distances comparable to the Debye length. For
example, in a 100-mM salt solution (where 1/k, the Debye
length, is ;1 nm) the potential a distance r ¼ 2 nm from the
charge q increases approximately twofold at the membrane
surface due to the perturbation of the double layer (Mathias
et al., 1992, see Fig. 4 and Eq. 10 for the complicated ex-
pression that describes the potential).
A surprisingly simple expression for the potential emerges
when the membrane phase has both a low dielectric and
excludes ions. For a charge q far from the interface in the
aqueous phase, the monovalent ions in solution ‘‘screen’’ the
charge, and the potential is described by Debye-Hu¨ckel
theory: ca ¼ q exp(kr) / (4peoear) where r is the distance
from the charge. If the charge q is moved to the interface with
a low dielectric membrane phase (ea / em 1) the potential in
the aqueous phase is simply ;2 times the Debye-Hu¨ckel
FIGURE 12 Electrostatic potentials produced by basic
peptides FA-MARCKS(151–175) or Lys-13. (A) FA-
MARCKS(151–175) (colored green) binds to a 5:1 PC/
PS membrane; a single PIP2 (colored yellow) is visible far
from the peptide in the upper right-hand side of the bilayer.
The blue and red meshes show 125 and 25 mV
equipotential proﬁles. (B) FA-MARCKS(151–175) binds
to a 5:1 PC/PS membrane and sequesters a PIP2. (C) FA-
MARCKS(151–175) in 100 mM KCl solution. The blue
line shows a two-dimensional representation of the 125
mV equipotential proﬁle. In panels D, E, and F the peptide
is adsorbed to a 5:1 PC/PS bilayer and viewed from above.
For clarity, we do not show the membrane and 25 mV
potential proﬁle. (D) FA-MARCKS(151–175) binds to
a 5:1 PC/PS membrane; (E) membrane-bound FA-
MARCKS(151–175) sequesters a PIP2; (F) membrane-
bound Lys-13.
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expression at all distances r from the charge (Mathias et al.,
1992, see Fig. 3; Stillinger, 1961).
Of course, only the acyl chain region of a phospholipid
bilayer has a dielectric ;2: the polar headgroup region
contains ;50% water by volume, and its average dielectric
constant is signiﬁcantly higher. Nevertheless, the two factors
discussed above should approximately double the potential
produced by a charge on a peptide (at least for r[ 1/k ;1
nm, z ¼ distance from surface ¼ 0) when the charge is
located within the polar headgroup region. These electro-
static phenomena provide a simple explanation for the
ability of aromatic residues to enhance the sequestration of
PIP2 by clusters of basic residues observed in Figs. 6, 8, and
13 B.
The energy required to increase the electrostatic potential
adjacent to the basic residues comes from the hydrophobic
energy gained by insertion of the Phe residues into the acyl
chain region of the membrane (Fig. 1 B). Engelman et al.
(1986) estimate this energy is ;4 kcal/mol per Phe residue,
sufﬁcient to account for the observed effects.
More detailed, realistic theoretical calculations are highly
model dependent, and are not presented here. We merely
note that J. Wang (unpublished) has shown that the potential
produced by a model basic peptide does increase in the
expected manner as the charges on the peptide approach the
polar headgroup interface of an atomic model of a bilayer
similar to that shown in Fig. 12.
Biological implications
MARCKS(151–175) sequestration of PIP2 on LUVs inhibits
PLC-catalyzed hydrolysis of PIP2
Fig. 13 A plots the % PIP2 hydrolyzed in PC/PS/PIP2 LUVs
as a function of time. In the absence of PLC-d1 (.), we
observed no signiﬁcant hydrolysis over 15 min, whereas
addition of enzyme produced signiﬁcant hydrolysis of PIP2
within the ﬁrst 3 min (d). Adding 0.5 mM MARCKS(151–
175) with the PLC () decreased the initial rate of hydrolysis
by;50%. Fig. 13 B shows the effect of peptide on the initial
rate of hydrolysis seen in Fig. 13 A, along with the results of
similar experiments done with different concentrations of
MARCKS(151–175). MARCKS(151–175) inhibits PLC-d1
activity in a concentration-dependent manner, with 0.3–0.5
mM peptide producing ;50% inhibition. The simplest
interpretation is that the PLC-d1 cannot hydrolyze seques-
tered PIP2. Fig. 13 B also shows that MARCKS(151–175)
inhibits PLC activity approximately fourfold more effec-
tively than FA-MARCKS(151–175). This result is consistent
with the more direct FRET (Fig. 6) and quenching (Fig. 8)
results indicating that aromatics enhance the sequestration of
PIP2. Finally, Fig. 13 B shows 0.5 mM Lys-13 produces
greater inhibition than 0.75 mM FA-MARCKS(151–175),
providing additional evidence that a higher linear density of
positive charges enhances PIP2 sequestration. As noted with
the FRET results, the Texas Red label on the peptides may be
enhancing the sequestration. This ﬂuorophore is hydropho-
bic and may, like the Phe residues, enhance the electro-
static potential of the peptide by pulling the adjacent basic
residues deeper into the headgroup. Indeed, Texas Red-
MARCKS(151–175) and Texas Red FA-MARCKS(151–
175) both increased inhibition of PLC-induced PIP2
hydrolysis compared to an equivalent concentration of their
unlabeled counterparts (Fig. 13 B). Attaching a hydrophobic
ﬂuorescent probe to a basic peptide corresponding to a region
of gelsolin also enhanced its ability to bind PIP2 (Cunning-
ham et al., 2001).
FIGURE 13 Inhibition of PLC-d1-catalyzed hydrolysis of PIP2 by
peptides that sequester PIP2. (A) The % accessible PIP2 hydrolyzed versus
time after addition of PLC-d1. These data are for zero peptide (d) and 0.5
mM MARCKS(151–175) (). A control with no PLC shows no hydrolysis
(.), as expected. The results illustrate the average of six separate
experiments. (B) Bar graph of relative PLC-d1 activity, calculated from
the initial slopes of hydrolysis versus time curves similar to those shown in
A. These bars represent an average of six experiments (6SD) for each
peptide. LUVs were composed of PC/PS/3H-PIP2 (83:17:0.15); 0.2 mM
total lipid concentration. Solution contains 100 mM KCl, 25 mM HEPES,
100 mM EGTA, 102 mM CaCl2 (;5 mM free Ca
21), 2 mM DTT, ;10 nM
PLC-d1, pH 7.0.
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MARCKS(151–175) sequestration of PIP2 on LUVs has little
effect on binding of the PLC-d1 PH domain to the vesicles
Previous work (Harlan et al., 1994; Lemmon et al., 1995;
Garcia et al., 1995) and our centrifugation experiments (not
shown) demonstrated that the EGFP-PLC-d1 PH domain
construct binds to PIP2 in membranes with signiﬁcant
afﬁnity (Kd ¼ 2 mM) and great speciﬁcity. As shown in
Fig. 14, the binding of EGFP-PH (d) to PC/PIP2 (99:1)
vesicles or to PC/PS/PIP2 (82:17:1) vesicles did not change
markedly as the MARCKS(151–175) concentration in-
creased from 0 to 5 mM. The accessible PIP2 concentration
is 4 mM in these vesicles, and our FRET, quenching, EPR,
and PLC experiments indicate[4 mMMARCKS(151–175)
should sequester[90% of the PIP2. Nevertheless, most of
the EGFP-PH domain remains bound to the vesicles even at
the highest peptide concentration. If most of the PIP2 in these
vesicles is indeed sequestered, there should be a marked
decrease in the binding of neomycin, which forms a 1:1
electroneutral complex with PIP2 (Arbuzova et al., 2000a).
Fig. 14 also shows the binding of FITC-neomycin (), which
decreases in the expected manner as MARCKS(151–175)
sequesters PIP2. (We also performed controls using a trace
concentration of 3H-MARCKS(151–175) to ensure that the
unlabeled MARCKS(151–175) was indeed sequestering the
PIP2 in these vesicles. As expected, the binding of
3H-
MARCKS(151–175) (data not shown) decreases in a manner
similar to FITC-neomycin.)
The simplest interpretation of these results is that
MARCKS(151–175) may electrostatically sequester not only
PIP2 but also the PH domain bound to PIP2, as illustrated in
Fig. 15. Fig. 15 A (equilibrium 1) illustrates our main con-
clusion from FRET, quenching, and ESR experiments: mem-
brane-bound MARCKS(151–175) laterally sequesters PIP2
because the local positive potential around the peptide
electrostatically attracts the negatively charged PIP2 (Fig. 15
B). The PLC-d1 PH domain, illustrated bound to PIP2 on the
membrane in equilibrium 2 of Fig. 15 A, has a patch of acidic
residues on its surface that produces a high local negative
potential. This negative potential, which is apparent in the side
and top views shown in Fig. 15, C and D, should also be
sequestrated by the positively charged MARCKS(151–175)
(equilibrium 3 in Fig. 15 A). There is strong support for equi-
libria 1 and 2; the evidence for equilibrium 3 is still indirect.
This putative lateral interaction between themembrane-bound
PH domain and clusters of basic residues has interesting
implications for the use of this PH domain as a probe of the
free concentration of PIP2 in the membrane (Balla andVarnai,
2002). It also implies that MARCKS may act as a scaffolding
protein: scaffolding proteins typically bind both enzymes and
their substrates (Burack and Shaw, 2000; Edwards and Scott,
2000). The available evidence suggests the effector domain of
MARCKS sequesters both PLC-d1 (through its PH domain)
and its substrate, PIP2; some ion channels also sequester both
PLC and PIP2 (Runnels et al., 2002).
DISCUSSION
The effector domain of MARCKS sequesters PIP2
The working hypothesis is that adsorption of the basic
effector domain of MARCKS to the inner leaﬂet of the
plasma membrane produces a local positive electrostatic
potential that reversibly sequesters a signiﬁcant fraction of
the polyvalent acidic lipid PIP2 in the cell. We used three
techniques to show that a peptide corresponding to the basic
effector domain, MARCKS(151–175), indeed sequesters
PIP2 laterally in the presence of much higher, physiologi-
cally relevant concentrations of the monovalent acidic lipid
PS. FRET from the Bodipy-TMR label on PIP2 to the Texas
Red label on MARCKS(151–175) shows that membrane-
bound MARCKS(151–175) sequesters PIP2, even when PS
is present at a 300-fold excess (Figs. 3–6). Fluorescence
quenching (Figs. 7 and 8) and EPR measurements (Figs. 10
and 11) show that unlabeled MARCKS(151–175) also
FIGURE 14 Effect of PIP2 sequestration on the binding of EGFP-PH and
FITC-Neomycin to LUVs. (A) Binding of EGFP-PH domain from PLC-d1
(d) or FITC-Neomycin () to PC/PIP2 (99:1) LUVs plotted against
MARCKS(151–175) concentration. Lipid concentration 0.8 mM; EGFP-PH
domain or FITC-Neomycin concentration ;10 nM. Solutions contain 100
mM KCl, 1 mM MOPS, 100 mM EDTA, 2 mM DTT, 0.0065% Triton
X-100, pH 7.0. (B) Binding of EGFP-PH domain (d) or FITC-Neomycin ()
to PC/PS/PIP2 (79:20:1) LUVs. All data points are an average of nine
experiments (6SD).
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laterally sequesters ﬂuorescent and spin-labeled PIP2 in the
presence of excess PS.
The sequestration is due to electrostatics
Does MARCKS(151–175) sequester PIP2 laterally by means
of local electrostatics? Previous theoretical calculations
using the nonlinear Poisson-Boltzmann equation (Arbuzova
et al., 1998; Murray et al., 1999, 2002; Wang et al., 2002;
McLaughlin et al., 2002), and those illustrated in Fig.12 of
this report, demonstrate that adsorption of a polybasic
peptide to a bilayer containing 15–35% monovalent acidic
lipid produces a local positive potential that can sequester
polyvalent phosphoinositides such as PIP2 and PIP3. Cal-
culations illustrated in Fig. 12 suggest that the sequestration
of PIP2 is signiﬁcant, even when the membrane contains
a large excess of monovalent acidic lipid such as PS (Wang
et al., 2003).
The predicted sequestration follows from the Boltzmann
relation and the high valence of PIP2. Fig. 12 illustrates the
potential is ;130 mV close to the basic peptide and ;30
mV far from it. The Boltzmann equation predicts that a lipid
with a valence of 4 (e.g., PIP2) will be concentrated or
sequestered 1000-fold more effectively than a lipid with
a valence of 1 (e.g., PS) if we assume, for simplicity in
illustrating the phenomenon, that monovalent and tetravalent
lipids are point charges that do not perturb the potential. The
calculations summarized in Fig. 12 take into account the fact
that PIP2 modiﬁes the potential as it approaches the
membrane-bound peptide. These calculations are presented
FIGURE 15 MARCKS(151–175) laterally sequesters the PIP2-bound PH domain of PLC-d1 as well as PIP2. (A) See text for description of cartoon.
Equilibrium 1: membrane-bound MARCKS(151–175) (blue ovals represent the 13 basic residues; green ovals the ﬁve phenylalanine residues) laterally
sequesters PIP2 (red). Equilibrium 2: The PLC-d1 PH domain (light green) binds to PIP2 (red) with high speciﬁcity; PIP2 forms multiple hydrogen bonds with
positively charged residues (blue1 signs) in the binding pocket. Equilibrium 3: We propose that the PIP2-bound PH domain, which contains a patch of acidic
residues (red  signs) on its surface, is (like PIP2) sequestered electrostatically by the membrane-bound MARCKS(151–175). Panel B shows the potential
produced by PIP2 (yellow) on a PC membrane. Panel C shows the potential produced by PIP2-bound PH domain (green) on a PC membrane as viewed from
the side. Panel D illustrates the view from the top of the membrane: 25 mV and 125 mV potential proﬁles are shown in red and blue; salt concentration ¼
100 mM.
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in more detail in the companion report (Wang et al., 2003).
These detailed electrostatic calculations and the thermody-
namic model of Haleva et al. (2003), which treats the peptide
as a uniformly charged disk, indicate that PIP2 will be
sequestered strongly in the presence of monovalent acidic
lipids.
The available experimental evidence supports these
theoretical predictions that nonspeciﬁc electrostatics can
account for this preferential sequestration of PIP2. The
experiments shown in Fig. 9 illustrate that increasing the salt
concentration decreases the sequestration, the result ex-
pected from double-layer theory (PB equation) if the seques-
tration is due to electrostatics (Wang et al., 2003; Haleva
et al., 2003). Furthermore, three results from experiments
measuring the binding of basic peptides to PC/PIP2 vesicles
strongly suggest the peptide-PIP2 interaction is due mainly to
electrostatics. First, the binding is independent of the
chemical nature of the basic residues: Lys-13 and Arg-13
peptides bind to PC/PIP2 99:1 vesicles with the same molar
partition coefﬁcient, K ¼ 106 M1, (Wang et al., 2002).
Second, the binding does not depend on the chemical nature
of the phosphoinositide: MARCKS(151–175) binds equally
well to PC/PIP2 vesicles containing either PI (3,4)P2 or PI
(4,5)P2 (Wang et al., 2001). Third, increasing the salt
concentration decreases the binding of the peptides to PC/
PIP2 vesicles (Wang et al., 2001, 2002). Although the
binding of basic peptides to PC/PIP2 vesicles and the
sequestration of PIP2 by the peptide bound to PC/PS/PIP2
vesicles both involve an electrostatic interaction between
PIP2 and the peptide, there are important differences: the
binding increases exponentially with valence of the peptide
(Wang et al., 2002), whereas the sequestration is not strongly
dependent on the valence (Fig. 6).
Binding of peptides to vesicles versus
sequestration of PIP2 by a membrane-bound
peptide
Our experimental results illustrate an important difference
between binding and sequestration. Lys-7 binds to PC/PIP2
(99:1) vesicles with a molar partition coefﬁcient K ¼ 103
M1; Lys-13 binds to these PC/PIP2 vesicles with K ¼ 106
M1 (Wang et al., 2002). The 1000-fold difference between
the afﬁnities of Lys-7 and Lys-13 for PC/PIP2 vesicles is
also manifested in their binding to 5:1 PC/PS vesicles (Wang
et al., 2002). This difference is well understood theoretically
and can be calculated from the ﬁrst principles using the PB
equation (Murray et al., 2002). The essence of the calculation
is easy to understand: the positively charged peptides
accumulate in the diffuse double layer adjacent to the
negatively charged vesicles. If c(x) is the potential at
a distance x from the surface and we assume, to simplify the
discussion, that the peptide is a point charge of valence z that
does not perturb the potential, the Boltzmann equation gives
the peptide concentration at x: P(x) ¼ P(‘) exp(zec(x) / kT).
The integral of the excess peptide concentration, P(x) 
P(‘), over the double layer (a few Debye lengths in
thickness; 1/k ;1 nm for 100 mM salt) gives the Gibbs
surface excess, which may be regarded as the number of
‘‘bound’’ peptides per unit area of membrane. If addition of
six basic residues (Lys-13 versus Lys-7) increases the
binding 1000-fold, it is apparent that each of these six basic
residues experiences an average potential of about 30 mV
when the peptide binds. Indeed, this is the average potential
a few angstroms from a 5:1 PC/PS vesicle; the potential may
be calculated from the Helmholtz capacitor equation
(McLaughlin, 1977), Gouy-Chapman theory (McLaughlin,
1989), the application of the nonlinear PB equation to an
atomic level model of a PC/PS membrane (Peitzsch et al.,
1995; Murray et al., 2002), or measured experimentally by
a number of different techniques (e.g., the z-potential of a 5:1
PC/PS vesicle in 100 mM salt is salt is 30 mV
(McLaughlin, 1989). The more realistic theoretical treatment
based on atomic models of membranes and peptides using
the nonlinear PB equation is reviewed elsewhere (Murray
et al., 2002). Theory predicts that the valence of the peptide
is a major factor in determining how strongly an unstructured
basic peptide binds electrostatically to a PC/PS or PC/PIP2
vesicle. The results with all the basic peptides we have
examined support this prediction (Wang et al., 2002).
Now consider the case where either a membrane-bound
Lys-7 or Lys-13 sequesters PIP2 (present at trace concen-
trations, e. g., 0.1%) in a PC/PS/PIP2 vesicle. The experi-
mental results reported here show that these two membrane-
bound peptides produce a similar sequestration of PIP2.
(Speciﬁcally the Bodipy-TMR label on PIP2 undergoes
FRET with the Texas Red label on Lys-7 and Lys-13 with
about the same efﬁciency (Fig. 6).) It is the valence of the
lipid, not the membrane-bound peptide, that is the more
important factor for lateral electrostatic sequestration. PIP2,
with a valence of;4, experiences a high positive potential
adjacent to both membrane-adsorbed peptides.
Embedded aromatics increase
electrostatic sequestration
Our experimental results show that replacing the aromatic
Phe residues in MARCKS(151–175) with Ala decreases the
lateral sequestration of PIP2 by a membrane-bound peptide
(compare MARCKS(151–175) and FA-MARCKS(151–
175) in Figs. 6, 8, and 13). The FA-MARCKS peptide does
not penetrate the bilayer, whereas the ﬁve Phe residues of
the MARCKS peptide drag the adjacent basic residues into
the polar headgroup region (Fig. 1 B), and thus increase the
potential they produce (Mathias et al., 1992).
Biological correlations
We previously compared the nonspeciﬁc electrostatic
sequestration of PIP2 by unstructured clusters of basic/
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aromatic residues on proteins to the highly speciﬁc binding
of PIP2 to structured domains, such as the PH domain of
PLC-d1 (McLaughlin et al., 2002; Wang et al., 2002). We
now argue that biology utilizes both types of interactions to
produce a ﬂow of information in signal transduction systems.
Our working hypothesis is that MARCKS reversibly seques-
ters a signiﬁcant fraction of the PIP2 (and PIP3) in the inner
leaﬂet of the plasma membrane (Laux et al., 2000;
McLaughlin et al., 2002). One important caveat is that the
concentration of MARCKS and other putative PIP2 buffers
(e.g., GAP43, CAP23) in many cell types is not well
established, and may not be sufﬁciently high to buffer
a signiﬁcant fraction of the PIP2. Six cell biology experi-
ments, however, provide support for our hypothesis: i), Laux
et al. (2000) showed overexpression of MARCKS in neuro-
nal or epithelial cells produces an increase in the total level of
PIP2 in the cell, which is the anticipated result if the higher
MARCKS concentration reduces the level of free PIP2,
causing the cell to compensate by increasing PIP2 production
to maintain a constant free PIP2 level; ii), MARCKS is not
uniformly distributed in the plasma membrane of some cell
types; it is concentrated in the rufﬂes of ﬁbroblasts (Myat
et al., 1997) and the nascent phagosomes of macrophages
(Allen and Aderem, 1995), presumably because of its
interaction with actin. The hypothesis predicts that PIP2 also
should be concentrated in these membrane rufﬂes and
nascent phagosomes. It is based on experiments that use
a ﬂuorescent construct of the PH domain of PLC-d1 to detect
PIP2 (Botelho et al., 2000; Tall et al., 2000). Interestingly,
the concentration of PIP kinases is also elevated in both these
areas (Doughman et al., 2003a). Hence both local synthesis
and sequestration could contribute to the accumulation of
PIP2 (Doughman et al., 2003b); iii), membrane rufﬂes (M.
Rebecchi, SUNY Stony Brook, NY, personal communica-
tion) and nascent phagosomes (Marshall et al., 2001; Botelho
et al., 2000) exhibit steep gradients for polyphosphoinosi-
tides at their borders. Local synthesis alone, however, should
produce only a shallow concentration gradient as the PIP2
diffuses from the region of high local concentration. Lateral
sequestration, on the other hand, could produce sharp
gradients if the concentration of MARCKS falls sharply at
the edge of the rufﬂe or nascent phagosome; iv), experiments
by D. J. Olson and R. A. Anderson (U. Wisconsin-Madison,
personal communication) show that free PIP2 levels[0.1%
inhibit native PIP kinase I puriﬁed from erythrocytes,
whereas the phospholipids of the inner leaﬂet of most
plasma membranes comprise ;1% PIP2, suggesting indir-
ectly that ;90% of the PIP2 may be sequestered in some
manner; v), cytoskeleton-free microvesicles released from
erythrocytes contain only ;50% of the PIP2 in the
unperturbed membrane, suggesting much of the PIP2 in the
unperturbed membrane is not free to diffuse (Hagelberg and
Allan, 1990); and vi), J. Sable and M. P. Sheetz (Columbia
University, personal communication) have recently obtained
the best evidence to date that MARCKS reversibly se-
questers a signiﬁcant fraction of the PIP2 in a living ﬁbro-
blast cell. They performed two experiments that suggest the
level of free PIP2 increases at the plasma membrane when
MARCKS translocates from membrane to cytosol due to
PKC phosphorylation. In one experiment, they detect an
increase in the level of free PIP2 by measuring the increase in
membrane tension due to PIP2-dependent cytoskeleton-
plasma membrane adhesion as GFP-labeled MARCKS is
translocated from the plasma membrane. An important
control shows that activation of PKC in ﬁbroblasts lacking
MARCKS does not produce an increase in the level of free
PIP2.
Clusters of basic residues on other proteins
should also sequester PIP2 (and PIP3)
Many other proteins with clusters of basic residues interact
with membranes, and some are present at concentrations
sufﬁciently high that they, too, could sequester PIP2. For
example, neuronal cells have two other natively unfolded
proteins, CAP23 and GAP43, that are present at high
concentrations; their clusters of basic/aromatic residues may
also act to sequester PIP2 (Laux et al., 2000). Several
scaffolding proteins have properties that suggest they also
could act as reversible PIP2 buffers. Drosophila A kinase
anchor protein 200 (DAKAP200) (Rossi et al., 1999)
contains a basic/aromatic region similar in structure to the
MARCKS effector domain, and a peptide corresponding to
this region binds strongly to PC/PIP2 vesicles (Wang et al.,
2002). The mammalian scaffolding protein AKAP79 con-
tains clusters of basic residues that are capable of binding
PIP2 (Dell’Acqua et al., 1998); Src-suppressed C kinase
substrate, SSeCKS, also has a cluster of basic/aromatic
residues that resembles the MARCKS effector domain
(Gelman, 2002).
In summary, the biophysical results reported here on
model systems support the hypothesis that an unstructured
cluster of basic/aromatic residues on MARCKS is capable of
reversibly sequestering a signiﬁcant fraction of the PIP2 on
the inner leaﬂet of a plasma membrane.
APPENDIX 1: PHOSPHOLIPID VESICLES ARE
SURPRISINGLY PERMEABLE TO
FLUORESCENTLY LABELED
BASIC AND BASIC/AROMATIC PEPTIDES
Our measurements (Fig. 5) show that FRET approaches 100% at high Texas
Red MARCKS(151–175) concentrations. The simplest interpretation of this
observation is that labeled MARCKS(151–175) rapidly crosses the bilayer
and binds to the ﬂuorescent PIP2 on the inner as well as the outer leaﬂet of
LUVs. We investigated this further by performing epi-ﬂuorescence
microscope experiments on giant ($5 mm) vesicles. The conventional
hydration method of forming giant vesicles (Akashi et al., 1996) produces
a mixture of unilamellar vesicles, multilamellar vesicles, and unilamellar
giant outer vesicles that contain smaller vesicles inside. We conﬁrmed the
smaller vesicles were inside the giant vesicle and were not merely
invaginations of the outer membrane by observing them at different focal
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depths and noting their Brownian movements inside the giant vesicle. We
added Texas Red MARCKS(151–175) to a solution of these vesicles on
a glass slide, then used a conventional epi-ﬂuorescence microscope with
a CCD camera to observe whether Texas Red MARCKS(151–175) binds
rapidly to the small inner vesicles enclosed by giant vesicles. Fig. 16 shows
one example of such an experiment: Texas Red MARCKS(151–175) does
indeed permeate the outer membrane rapidly (\1 min) and binds to the inner
vesicles, which we stress are not invaginations of the outer bilayer. We
observed rapid permeation in >100 vesicles in these experiments. This
technique permitted us to discard any false positives resulting from
observations of smaller vesicles tethered to giant vesicles or aggregates of
many vesicles. The lipid composition in Fig. 16 is PC/PS/PIP2 (70:30:0.1).
Rapid permeation of the labeled peptide is also observed with PC/PS (5:1)
vesicles (data not shown).
We are surprised that the bilayer is permeable to a peptide with 13 basic
residues; Born calculations (Parsegian 1969), and many experiments with
simple ions and small basic peptides, indicate phospholipid bilayers are not
generally permeable to charged molecules. ‘‘Trojan’’ peptides, a class of
highly basic or basic/aromatic peptides, are known to penetrate biological
membranes, however, and can even be used to deliver covalently attached
‘‘cargo’’ into cells by an unknown mechanism (Lindgren et al., 2000; Binder
and Lindblom, 2003).
We have not investigated the mechanism by which the ﬂuorescently
labeled peptides permeate phospholipid bilayers in any detail. The Texas
Red labels are large (;700 Da) and hydrophobic; they almost certainly
penetrate into the acyl chain region of the bilayer, as do the Phe residues
illustrated in Fig. 1 B. These hydrophobic groups do not provide enough
energy to solubilize the 13 charges on MARCKS(151–175) in the low
dielectric interior of the bilayer (Parsegian 1969). They may, however, act in
a number of different ways: inducing local curvature that destabilizes the
membrane; stabilizing the spontaneously occurring, transient water-ﬁlled
pores in the bilayer; and/or aggregating laterally to form alamethicin-like
pores that allow penetration of the pore-forming molecules (Lindgren et al.,
2000; Biggin and Sansom, 1999). We note that the Texas Red Lys-7 also
permeates rapidly, suggesting aromatic residues on the peptide are not
required. Furthermore, we see similar permeation (and similar 100% FRET)
of MARCKS(151–175) labeled with the smaller hydrophobic probes
Oregon Green (;450 Da) and Bodipy-507 (;300 Da) (results not shown).
Cunningham et al. (2001) observed that attaching a hydrophobic ﬂuorescent
probe, rhodamine B, to a basic peptide corresponding to a region of gelsolin
allows the peptide to cross the cell membrane by an unknown mechanism. In
contrast, we did not observe permeation of the bilayer using a peptide with
a hydrophilic label, Alexa-488-MARCKS(151–175) (data not shown), but
found that adding Texas Red MARCKS(151–175) and Alexa-488-
MARCKS(151–175) together allows the latter peptide to permeate (not
shown), suggesting strongly that a transient pore is formed.
APPENDIX 2: Effects of cholesterol on the binding
of MARCKS(151–175) to vesicles
As we discuss in the Introduction, EPR (Qin and Caﬁso, 1996; Victor et al.,
1999) and NMR (Zhang et al., 2003; Ellena et al., 2003) experiments
indicate that the phenylalanine residues on the MARCKS peptide penetrate
into the acyl chain region of the bilayer, as shown in Fig. 1 B. Thus the
backbone of the adjacent residues must be dragged deep into the polar
headgroup region (Fig. 1 B). If the surface pressure in the polar headgroup
region is comparable to that in the acyl chain region, the work required to
bury the backbone and these residues in the polar headgroup region could be
large. We reasoned that less work would be required if the membrane
contained lipids with a very small polar headgroup such as cholesterol:
cholesterol could diffuse into the region adjacent to the bound peptide,
reducing local surface pressure. Thus, we investigated whether
MARCKS(151–175) binds more strongly to phospholipid vesicles that
contain cholesterol. We found that radioactively labeled MARCKS(151–
175) binds with exactly the same molar partition coefﬁcient to PC/PS
(88:12) vesicles and to PC/PS/Ch (7:1:3) vesicles that contain a mol fraction
of PS required to exactly match the z-potential of the PC/PS vesicles (data
not shown). This observation is consistent with measurements on
monolayers that show binding of ;1 MARCKS(151–175) per 100 lipids
on a PC/PS/PIP2 (70:30:1) monolayer produces only a small increase in the
surface pressure (\1 mN/m; data not shown). The simplest, albeit
speculative, interpretation is that the surface pressure in the polar headgroup
region of a bilayer formed from lipids with unsaturated acyl chains is low,
and that the insertion of peptides into this region can be accomplished with
very little work against this surface pressure.
Caroni and colleagues (Laux et al., 2000; Caroni, 2001) suggested the
MARCKS protein (and two neuronal proteins, GAP43 and CAP23) may be
concentrated in cholesterol-enriched domains, or rafts, in cells, because
these proteins bind to PIP2 that is apparently concentrated in these
cholesterol-enriched domains (Pike and Miller, 1998). We wanted to
explore whether there is an obvious relationship between MARCKS(151–
175), PIP2, and cholesterol-enriched rafts in a simple model system. We
used epi-ﬂuorescence microscopy to observe large ([5 mm) cholesterol-
enriched domains that form spontaneously in monolayers (Keller, 2002;
Radhakrishnan and McConnell, 1999). We observed that PIP2 is excluded
from the cholesterol-enriched domains, as monitored by its ability to bind
either EGFP-PH or MARCKS(151–175) from the subphase (not shown);
Bodipy-TMR-PIP2 is also excluded. The exclusion of PIP2 from these
cholesterol-enriched domains in simple model systems is expected because
PIP2 contains a polyunsaturated chain (Silvius, 2003; Brown and London,
2000). Of course these experiments on rafts in a simple model system cannot
easily be extrapolated to living cells: the size, composition, lifetime, and
mechanism of formation of putative rafts in cell membranes are all still
unknown (Edidin, 2003; McIntosh et al., 2003).
This work was supported by the National Institutes of Health (grant
GM24971 to S.M., GM62305 to D.C., and GM69651 to S.S.) and by the
National Science Foundation (grant MCB0212362 to D.M.).
REFERENCES
Aderem, A. 1992. The MARCKS brothers: a family of protein kinase C
substrates. Cell. 71:713–716.
FIGURE 16 Texas Red MARCKS(151–175) permeates giant unilamellar
vesicles. We observed Texas Red ﬂuorescence immediately (;10 s) after
addition of Texas Red MARCKS(151–175) to a solution containing a giant
(;10 mm) vesicle enclosing four smaller vesicles. Epi-ﬂuorescence
microscopy reveals Texas Red MARCKS(151–175) binds rapidly to the
inner vesicles. Lipid composition: PC/PS/PIP2 (69:30:0.1); peptide con-
centration: ;100 nM.
2204 Gambhir et al.
Biophysical Journal 86(4) 2188–2207
Akashi, K., H. Miyata, H. Itoh, and K. Kinosita, Jr. 1996. Preparation of
giant liposomes in physiological conditions and their characterization
under an optical microscope. Biophys. J. 71:3242–3250.
Albert, K. A., A. C. Nairn, and P. Greengard. 1987. The 87-kDa protein,
a major speciﬁc substrate for protein kinase C: puriﬁcation from bovine
brain and characterization. Proc. Natl. Acad. Sci. USA. 84:7046–7050.
Allen, L. A., and A. Aderem. 1995. A role for MARCKS, the a isozyme of
protein kinase C and myosin I in zymosan phagocytosis by macrophages.
J. Exp. Med. 182:829–840.
Arbuzova, A., K. Martushova, G. Hangyas-Mihalyne, A. J. Morris, S.
Ozaki, G. D. Prestwich, and S. McLaughlin. 2000a. Fluorescently
labeled neomycin as a probe of phosphatidylinositol-4, 5-bisphosphate in
membranes. Biochim. Biophys. Acta. 1464:35–48.
Arbuzova, A., D. Murray, and S. McLaughlin. 1998. MARCKS,
membranes, and calmodulin: kinetics of their interaction. Biochim.
Biophys. Acta. 1376:369–379.
Arbuzova, A., A. A. Schmitz, and G. Vergeres. 2002. Cross-talk unfolded:
MARCKS Proteins. Biochem. J. 362:1–12.
Arbuzova, A., L. Wang, J. Wang, G. Hangyas-Mihalyne, D. Murray,
B. Honig, and S. McLaughlin. 2000b. Membrane binding of peptides
containing both basic and aromatic residues. Experimental studies with
peptides corresponding to the scaffolding region of caveolin and the
effector region of MARCKS. Biochemistry. 39:10330–10339.
Aveyard, R., and D. A. Haydon. 1973. An Introduction to the Principles of
Surface Chemistry. Cambridge University Press, Cambridge, UK.
Balla, T., and P. Varnai. 2002. Visualizing Cellular Phosphoinositide Pools
with GFP-Fused Protein-Modules. STKE (http://www.stke.org/cgi/
content/full/OC_sigtrans); 2002/125/pl3:1–16.
Ben-Tal, N., B. Honig, R. M. Peitzsch, G. Denisov, and S. McLaughlin.
1996. Binding of small basic peptides to membranes containing acidic
lipids: theoretical models and experimental results. Biophys. J. 71:561–
575.
Berney, C., and G. Danuser. 2003. FRET or no FRET: a quantitative
comparison. Biophys. J. 84:3992–4010.
Berridge, M. J., M. D. Bootman, and H. L. Roderick. 2003. Calcium
signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell
Biol. 4:517–529.
Berridge, M. J., and R. F. Irvine. 1984. Inositol trisphosphate, a novel
second messenger in cellular signal transduction. Nature. 312:315–321.
Biggin, P. C., and M. S. Sansom. 1999. Interactions of alpha-helices with
lipid bilayers: a review of simulation studies. Biophys. Chem. 76:161–
183.
Binder, H., and G. Lindblom. 2003. Charge-dependent translocation of the
trojan peptide penetratin across lipids membranes. Biophys. J. 85:
982–995.
Blackshear, P. J. 1993. The MARCKS family of cellular protein kinase C
substrates. J. Biol. Chem. 268:1501–1504.
Botelho, R. J., M. Teruel, R. Dierckman, R. Anderson, A. Wells, J. D.
York, T. Meyer, and S. Grinstein. 2000. Localized biphasic changes in
phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J. Cell
Biol. 151:1353–1368.
Brooks, B. R., R. E. Bruccoleri, B. D. Olafson, D. J. States, S.
Swaminathan, and M. Karplus. 1983. CHARMM: a program for
macromolecular energy, minimization, and dynamics calculations.
J. Comput. Chem. 4:187–217.
Brown, D. A., and E. London. 2000. Structure and function of sphingolipid-
and cholesterol-rich membrane rafts. J. Biol. Chem. 275:17221–17224.
Bunce, C. M., P. H. French, P. Allen, J. C. Mountford, B. Moor, M. F.
Greaves, R. H. Michell, and G. Brown. 1993. Comparison of the levels
of inositol metabolites in transformed heamopoietic cells and their
normal counterparts. Biochem. J. 289:667–673.
Burack, W. R., and A. S. Shaw. 2000. Signal transduction: hanging on
a scaffold. Curr. Opin. Cell Biol. 12:211–216.
Buser, C. A., and S. McLaughlin. 1998. Ultracentrifugation technique for
measuring the binding of peptides and proteins to sucrose-loaded
phospholipid vesicles. Methods Mol. Biol. 84:267–281.
Buser, C. A., C. T. Sigal, M. D. Resh, and S. McLaughlin. 1994. Membrane
binding of myristylated peptides corresponding to the NH2-terminus of
Src. Biochemistry. 33:13093–13101.
Cantley, L. C. 2002. The phosphoinositide 3-kinase pathway. Science.
296:1655–1657.
Caroni, P. 2001. Actin cytoskeleton regulation through modulation of
PI(4,5)P2 rafts. EMBO J. 20:4332–4336.
Cremona, O., and P. De Camilli. 2001. Phosphoinositides in membrane
trafﬁc at the synapse. J. Cell Sci. 114:1041–1052.
Cunningham, C. C., R. Vegners, R. Bucki, M. Funaki, N. Korde, J. H.
Hartwig, T. P. Stossel, and P. A. Janmey. 2001. Cell permeant
polyphosphoinositide-binding peptides that block cell motility and actin
assembly. J. Biol. Chem. 276:43390–43399.
Czech, M. P. 2003. Dynamics of phosphoinositides in membrane retrieval
and insertion. Annu. Rev. Physiol. 65:791–815.
Dell’Acqua, M. L., M. C. Faux, J. Thorburn, A. Thorburn, and J. D. Scott.
1998. Membrane-targeting sequences on AKAP79 bind phosphatidyli-
nositol-4,5-bisphosphate. EMBO J. 17:2246–2260.
Dill, K. A., and S. Bromberg. 2003. Molecular Driving Forces: Statistical
Thermodynamics in Chemistry and Biology. Garland Science, New
York. 387–407.
Doughman, R. L., A. J. Firestone, M. L. Wojtasiak, M. W. Bunce, and
R. A. Anderson. 2003a. Membrane rufﬂing requires coordination be-
tween Type Ia phosphatidylinositol phosphate kinase and Rac signaling.
J. Biol. Chem. 278:23036–23045.
Doughman, R. L., A. J. Firestone, and R. A. Anderson. 2003b.
Phosphatidylinositol phosphate kinases put PI4,5P2 in its place.
J. Membr. Biol. 194:77–89.
Edidin, M. 2003. Lipids on the frontier: a century of cell-membrane
bilayers. Nat. Rev. Mol. Cell Biol. 4:414–418.
Edwards, A. S., and J. D. Scott. 2000. A-kinase anchoring proteins: protein
kinase A and beyond. Curr. Opin. Cell Biol. 12:217–221.
Ellena, J. F., M. C. Burnitz, and D. S. Caﬁso. 2003. Location of the
myristoylated alanine-rich C-kinase substrate (MARCKS) effector
domain in negatively charged phospholipid bicelles. Biophys. J. 85:
2442–2448.
Engelman, D. M., T. A. Steitz, and A. Goldman. 1986. Identifying nonpolar
transbilayer helices in amino acid sequences of membrane proteins.
Annu. Rev. Biophys. Biophys. Chem. 15:321–353.
Ferguson, K. M., M. A. Lemmon, J. Schlessinger, and P. B. Sigler. 1995.
Structure of the high afﬁnity complex of inositol trisphosphate with
a phospholipase C pleckstrin homology domain. Cell. 83:1037–1046.
Ferrell, J. E., and W. H. Huestis. 1984. Phosphoinositide metabolism and
the morphology of human erythrocytes. J. Cell Biol. 98:1992–1998.
Gallagher, K., and K. A. Sharp. 1998. Electrostatic contributions to heat
capacity changes of DNA-ligand binding. Biophys. J. 75:769–776.
Garcia, P., R. Gupta, S. Shah, A. J. Morris, S. A. Rudge, S. Scarlata, V.
Petrova, S. McLaughlin, and M. J. Rebecchi. 1995. The pleckstrin
homology domain of phospholipase C-d1 binds with high afﬁnity to
phosphatidylinositol 4,5-bisphosphate in bilayer membranes. Biochem-
istry. 34:16228–16234.
Gelman, I. H. 2002. The role of SSeCKS/gravin/AKAP12 scaffolding
proteins in the spaciotemporal control of signaling pathways in
oncogenesis and development. Front. Biosci. 7:d1782–d1797.
Groves, J. R., S. G. Boxer, and H. M. McConnell. 2000. Electric ﬁeld
effects in mulitcomponent ﬂuid lipid membranes. Phys. Chem. B.
104:119–124.
Hagelberg, C., and D. Allan. 1990. Restricted diffusion of integral
membrane proteins and polyphosphoinositides leads to their depletion
in microvesicles released from human erythrocytes. Biochem. J. 271:
831–834.
Haleva, E., N. Ben-Tal, and H. Diamant. 2003. Increased concentration of
polyvalent phospholipids in the adsorption domain of a charged protein.
Biophys. J. 86:2165–2178.
Electrostatic Sequestration of PIP2 2205
Biophysical Journal 86(4) 2188–2207
Harlan, J. E., P. J. Hajduk, H. S. Yoon, and S. W. Fesik. 1994. Pleckstrin
homology domains bind to phosphatidylinositol-4,5-bisphosphate. Na-
ture. 371:168–170.
Hilgemann, D. W., S. Feng, and C. Nasuhoglu. 2001. The Complex and
Intriguing Lives of PI(4,5)P2 with Ion Channels and Transporters. STKE
(http://www.stke.org/cgi/content/full/OC_sigtrans); 2001/111/re19:1–8.
Jackson, J. D. 1975. Classical Electrodynamics. Wiley, New York. 147–52.
Keller, S. 2002. Coexisting liquid phases in lipid monolayers and bilayers.
Journal of Physics: Condensed Matter. 14:4763–4766.
Kim, J., T. Shishido, X. Jiang, A. Aderem, and S. McLaughlin. 1994.
Phosphorylation, high ionic strength, and calmodulin reverse the binding
of MARCKS to phospholipid vesicles. J. Biol. Chem. 269:28214–28219.
Lakowicz, J. R 1999. Principles of Fluorescence Spectroscopy. Kluwer
Academic/Plenum Publishing, New York. 367–94.
Laux, T., K. Fukami, M. Thelen, T. Golub, D. Frey, and P. Caroni. 2000.
GAP43, MARCKS, and CAP23 modulate PI(4,5)P2 at plasmalemmal
rafts, and regulate cell cortex actin dynamics through a common
mechanism. J. Cell Biol. 149:1455–1472.
Lemmon, M. A. 2003. Phosphoinositide recognition domains. Trafﬁc.
4:201–213.
Lemmon, M. A., K. M. Ferguson, R. O’Brien, P. B. Sigler, and
J. Schlessinger. 1995. Speciﬁc and high-afﬁnity binding of inositol
phosphates to an isolated pleckstrin homology domain. Proc. Natl. Acad.
Sci. USA. 92:10472–10476.
Lim, W. A. 2002. The modular logic of signaling proteins: building
allosteric switches from simple binding domains. Curr. Opin. Struct.
Biol. 12:61–68.
Lindgren, M., M. Hallbrink, A. Prochiantz, and U. Langel. 2000. Cell-
penetrating peptides. Trends Pharmacol. Sci. 21:99–103.
Marshall, J. G., J. W. Booth, V. Stambolic, T. Mak, T. Balla, A. D.
Schreiber, T. Meyer, and S. Grinstein. 2001. Restricted accumulation of
phosphatidylinositol 3-kinase products in a plasmalemmal subdomain
during Fcg receptor-mediated phagocytosis. J. Cell Biol. 153:1369–
1380.
Martin, T. F. 2001. PI(4,5)P2 regulation of surface membrane trafﬁc. Curr.
Opin. Cell Biol. 13:493–499.
Mathias, R. T., G. J. Baldo, K. Manivannan, and S. McLaughlin. 1992.
Discrete charges on biological membranes. In Electriﬁed Interfaces in
Physics, Chemistry and Biology. R. Guidelli, editor. Kluwer Academic
Publishers, Dordrecht, The Netherlands. 473–90.
May, S., D. Harries, and A. Ben-Shaul. 2000. Lipid demixing and protein-
protein interactions in the adsorption of charged proteins on mixed
membranes. Biophys. J. 79:1747–1760.
McIntosh, T. J., A. Vidal, and S. A. Simon. 2003. Sorting of lipids and
transmembrane peptides between detergent-soluble bilayers and de-
tergent-resistant rafts. Biophys. J. 85:1656–1666.
McLaughlin, S. 1977. Electrostatic potentials at membrane-solution
interfaces. Current Topics in Membranes and Transport. 9:71–144.
McLaughlin, S. 1989. The electrostatic properties of membranes. Annu.
Rev. Biophys. Biophys. Chem. 18:113–136.
McLaughlin, S., and A. Aderem. 1995. The myristoyl-electrostatic switch:
a modulator of reversible protein-membrane interactions. Trends
Biochem. Sci. 20:272–276.
McLaughlin, S., J. Wang, A. Gambhir, and D. Murray. 2002. PIP2 and
proteins: interactions, organization, and information ﬂow. Annu. Rev.
Biophys. Biomol. Struct. 31:151–175.
Mitchell, K. T., J. E. Ferrell, Jr., and W. H. Huestis. 1986. Separation of
phosphoinositides and other phospholipids by two-dimensional thin-
layer chromatography. Anal. Biochem. 158:447–453.
Murray, D., A. Arbuzova, G. Hangyas-Mihalyne, A. Gambhir, N. Ben-Tal,
B. Honig, and S. McLaughlin. 1999. Electrostatic properties of mem-
branes containing acidic lipids and adsorbed basic peptides: theory and
experiment. Biophys. J. 77:3176–3188.
Murray, D., A. Arbuzova, B. Honig, and S. McLaughlin. 2002. The role of
electrostatic and nonpolar interactions in the association of peripheral
proteins with membranes. Curr. Top. Membr. 52:271–302.
Myat, M. M., S. Anderson, L. H. Allen, and A. Aderem. 1997. MARCKS
regulates membrane rufﬂing and cell spreading. Curr. Biol. 7:611–614.
Nicholls, A., K. A. Sharp, and B. Honig. 1991. Protein folding and
association: insights from the interfacial and thermodynamic properties
of hydrocarbon. Proteins. 11:281–296.
Ohmori, S., N. Sakai, Y. Shira, H. Yamamoto, E. Miyamoto, N. Shimizu,
and N. Saito. 2000. Importance of protein kinase C targeting for the
phosphorylation of its substrate, myristoylated alanine-rich C-kinase
substrate. J. Biol. Chem. 275:26449–26457.
Osborne, S. L., F. A. Meunier, and G. Schiavo. 2001. Phosphoinositides as
key regulators of synaptic function. Neuron. 32:9–12.
Parsegian, A. 1969. Energy of an ion crossing a low dielectric membrane:
solutions to four relevant electrostatic problems. Nature. 221:844–846.
Payrastre, B., K. Missy, S. Giuriato, S. Bodin, M. Plantavid, and M.
Gratacap. 2001. Phosphoinositides: key players in cell signalling, in time
and space. Cell. Signal. 13:377–387.
Peitzsch, R. M., M. Eisenberg, K. A. Sharp, and S. McLaughlin. 1995.
Calculations of the electrostatic potential adjacent to model phospholipid
bilayers. Biophys. J. 68:729–738.
Pentyala, S., E. Tall, S. Mathew, K. Tanguturi, P. Yalamanchili, and
M. Rebecchi. 2003 Fluorescent chimeras and living colors: unraveling
the mysteries of cell signaling—the story of phospholipase C-d1. In
Radiobiology and Biomedical Research. K. P. Mishra, editor. Narosa
Publishing House, New Delhi, India. 134–143.
Pike, L. J., and J. M. Miller. 1998. Cholesterol depletion delocalizes
phosphatidylinositol bisphosphate and inhibits hormone-stimulated
phosphatidylinositol turnover. J. Biol. Chem. 273:22298–22304.
Prescott, E. D., and D. Julius. 2003. A modular PIP2 binding site as
a determinant of capsaicin receptor sensitivity. Science. 300:1284–1288.
Qin, Z., and D. S. Caﬁso. 1996. Membrane structure of the protein kinase C
and calmodulin binding domain of myristoylated alanine rich C kinase
substrate determined by site-directed spin labeling. Biochemistry. 35:
2917–2925.
Radhakrishnan, A., and H. M. McConnell. 1999. Condensed complexes of
cholesterol and phospholipids. Biophys. J. 77:1507–1517.
Rauch, M. E., C. G. Ferguson, G. D. Prestwich, and D. S. Caﬁso. 2002.
Myristoylated alanine-rich C kinase substrate (MARCKS) sequesters
spin-labeled phosphatidylinositol-4,5-bisphosphate in lipid bilayers.
J. Biol. Chem. 277:14068–14076.
Raucher, D., T. Stauffer, W. Chen, K. Shen, S. Guo, J. D. York, M. P.
Sheetz, and T. Meyer. 2000. Phosphatidylinositol 4,5-bisphosphate
functions as a second messenger that regulates cytoskeleton-plasma
membrane adhesion. Cell. 100:221–228.
Rebecchi, M. J., and S. N. Pentyala. 2000. Structure, function, and control
of phosphoinositide-speciﬁc phospholipase C. Physiol. Rev. 80:1291–
1335.
Rhee, S. G. 2001. Regulation of phosphoinositide-speciﬁc phospholipase
C. Annu. Rev. Biochem. 70:281–312.
Rossi, E. A., Z. Li, H. Feng, and C. S. Rubin. 1999. Characterization of the
targeting, binding, and phosphorylation site domains of an A kinase
anchor protein and a myristoylated alanine-rich C kinase substrate-like
analog that are encoded by a single gene. J. Biol. Chem. 274:27201–
27210.
Roux, M., J. M. Neumann, M. Bloom, and P. F. Devaux. 1988. 2H and 31P
NMR study of pentalysine interaction with headgroup deuterated
phosphatidylcholine and phosphatidylserine. Eur. Biophys. J. 16:267–
273.
Runnels, L. W., L. Yue, and D. Clapham. 2002. The TRPM7 channel is
inactivated by PIP2 hydrolysis. Nat. Cell Biol. 4:329–336.
Sciorra, V. A., M. A. Frohman, and A. J. Morris. 2000. Regulation
of phospholipase D signaling by phosphoinositides. In Biology of
Phosphoinositides. S. Cockcroft, editor. Oxford University Press,
Oxford, UK.
2206 Gambhir et al.
Biophysical Journal 86(4) 2188–2207
Segrest, J. P., M. A. Jones, V. K. Mishra, and G. M. Anantharamaiah. 2002.
Experimental and computational studies of the interactions of amphi-
pathic peptides with lipid surfaces. In Peptide-Lipid Interactions. S. A.
Simon and T. J. McIntosh, editors. Academic Press, San Diego, CA.
397–435.
Silvius, J. R. 2003. Role of cholesterol in lipid raft formation: lessons from
lipid model systems. Biochim. Biophys. Acta. 1610:174–183.
Simon, S. A., and T. J. McIntosh. 2002. Peptide-Lipid Interactions.
Academic Press, San Diego, CA.
Simonsen, A., A. E. Wurmser, S. D. Emr, and H. Stenmark. 2001. The role
of phosphoinositides in membrane transport. Curr. Opin. Cell Biol.
13:485–492.
Stillinger, F. H. 1961. Interfacial solutions of the Poisson-Boltzmann
equation. J. Chem. Phys. 35:1584–1589.
Strandberg, E., S. Morein, D. T. Rijkers, R. M. Liskamp, P. C. van der Wel,
and J. A. Killian. 2002. Lipid dependence of membrane anchoring
properties and snorkeling behavior of aromatic and charged residues in
transmembrane peptides. Biochemistry. 41:7190–7198.
Swierczynski, S. L., and P. J. Blackshear. 1995. Membrane association of
the myristoylated alanine-rich C kinase substrate (MARCKS) protein.
Mutational analysis provides evidence for complex interactions. J. Biol.
Chem. 270:13436–13445.
Tall, E., I. Spector, S. N. Pentyala, I. Bitter, and M. J. Rebecchi. 2000.
Dynamics of phosphatidylinositol 4,5-bisphosphate in actin-supported
structures. Curr. Biol. 10:743–746.
Tran, D., P. Gascard, B. Berthon, K. Fukami, T. Takenawa, F. Giraud, and
M. Claret. 1993. Cellular distribution of polyphosphoinositides in rat
hepatocytes. Cell. Signal. 5:565–581.
Van Der Meer, B. W., G. Coker, and S. Y. S. Chen. 1994. Resonance
Energy Transfer: Theory and Data. VCH Publishers, New York.
Vanhaesebroeck, B., S. J. Leevers, K. Ahmadi, J. Timms, R. Katso, P. C.
Driscoll, R. Woscholski, P. J. Parker, and M. D. Waterﬁeld. 2001.
Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev.
Biochem. 70:535–602.
Victor, K., J. Jacob, and D. S. Caﬁso. 1999. Interactions controlling the
membrane binding of basic protein domains: phenylalanine and the
attachment of the myristoylated alanine-rich C-kinase substrate protein to
interfaces. Biochemistry. 38:12527–12536.
Wang, J., A. Arbuzova, G. Hangyas-Mihalyne, and S. McLaughlin. 2001.
The effector domain of myristoylated alanine-rich C kinase substrate
binds strongly to phosphatidylinositol 4,5-bisphosphate. J. Biol. Chem.
276:5012–5019.
Wang, J., A. Gambhir, G. Hangyas-Mihalyne, D. Murray, U. Golebiewska,
and S. McLaughlin. 2002. Lateral sequestration of phosphatidylinositol
4,5-bisphosphate by the basic effector domain of myristoylated alanine-
rich C kinase substrate is due to nonspeciﬁc electrostatic interactions.
J. Biol. Chem. 277:34401–34412.
Wang, J., A. Gambhir, S. McLaughlin, and D. Murray. 2003. A
computational model for the electrostatic sequestration of PI(4,5)P2 by
membrane-adsorbed basic peptides. Biophys. J. 86:1969–1986.
White, D. A. 1973. The phospholipid composition of mammalian tissues.
In Form and Function of Phospholipids. R. M. C. Dawson, J. N.
Hawthorne, and G. B. Ansell, editors. Elsevier Scientiﬁc Publishing
Company, Amsterdam, The Netherlands. 441–78.
Williams, R. L., and M. Katan. 1996. Structural views of phosphoinositide-
speciﬁc phospholipase C: signalling the way ahead. Structure. 4:1387–
1394.
Yamauchi, E., T. Nakatsu, M. Matsubara, H. Kato, and H. Taniguchi. 2003.
Crystal structure of a MARCKS peptide containing the calmodulin-
binding domain in complex with Ca21-calmodulin. Nat. Struct. Biol.
10:226–231.
Yin, H. L., and P. A. Janmey. 2003. Phosphoinositide regulation of the
actin cytoskeleton. Annu. Rev. Physiol. 65:761–789.
Yorek, M. A. 1993. Biological distribution. In Phospholipids Handbook. G.
Cevc, editor. Marcel Dekker, New York. 745–75.
Zhang, W., E. Crocker, S. McLaughlin, and S. O. Smith. 2003. Binding of
peptides with basic and aromatic residues to bilayer membranes:
phenylalanine in the MARCKS effector domain penetrates into the
hydrophobic core of the bilayer. J. Biol. Chem. 278:21459–21466.
Electrostatic Sequestration of PIP2 2207
Biophysical Journal 86(4) 2188–2207
